,dataset,split,model_name_or_path,train_roc,val_roc,test_roc,prompt
0,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4789682539682539,"APR_HepG2_CellCycleArrest_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellCycleArrest_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellCycleArrest_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""proliferation"". Is this molecule effective to this assay?",train
1,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5813008130081301,"APR_HepG2_CellCycleArrest_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellCycleArrest_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellCycleArrest_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""arrest"". Is this molecule effective to this assay?",train
2,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.523358585858586,"APR_HepG2_CellCycleArrest_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellCycleArrest_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellCycleArrest_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""proliferation"". Is this molecule effective to this assay?",train
3,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4742346938775511,"APR_HepG2_CellLoss_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellLoss_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellLoss_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
4,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5222277722277722,"APR_HepG2_CellLoss_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellLoss_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellLoss_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
5,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6393442622950819,"APR_HepG2_MicrotubuleCSK_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
6,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.42998585572843,"APR_HepG2_MicrotubuleCSK_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
7,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5013550135501355,"APR_HepG2_MicrotubuleCSK_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
8,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.441923076923077,"APR_HepG2_MicrotubuleCSK_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
9,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6253588516746411,"APR_HepG2_MitoMass_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_24hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
10,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7048387096774194,"APR_HepG2_MitoMass_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_24hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
11,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.618172268907563,"APR_HepG2_MitoMass_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_72hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
12,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5121082621082621,"APR_HepG2_MitoMass_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_72hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
13,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.445578231292517,"APR_HepG2_MitoMembPot_1hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_1hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMembPot_1hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMembPot_1h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
14,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6079252577319588,"APR_HepG2_MitoMembPot_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMembPot_24hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMembPot_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
15,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6385964912280702,"APR_HepG2_MitoMembPot_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMembPot_72hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMembPot_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
16,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5982603092783505,"APR_HepG2_MitoticArrest_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoticArrest_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MitoticArrest_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""arrest"". Is this molecule effective to this assay?",train
17,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6222784810126581,"APR_HepG2_MitoticArrest_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoticArrest_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MitoticArrest_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""arrest"". Is this molecule effective to this assay?",train
18,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5853658536585367,"APR_HepG2_NuclearSize_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_NuclearSize_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_NuclearSize_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
19,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.502710027100271,"APR_HepG2_NuclearSize_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_NuclearSize_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_NuclearSize_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
20,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5590551181102362,"APR_HepG2_NuclearSize_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_NuclearSize_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_NuclearSize_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
21,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4468085106382978,"APR_HepG2_StressKinase_1hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_1hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_StressKinase_1hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_StressKinase_1h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""stress response"". Is this molecule effective to this assay?",train
22,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5385208012326657,"APR_HepG2_StressKinase_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_StressKinase_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_StressKinase_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""stress response"". Is this molecule effective to this assay?",train
23,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.623444976076555,"APR_HepG2_StressKinase_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_StressKinase_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_StressKinase_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""stress response"". Is this molecule effective to this assay?",train
24,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.621994342291372,"APR_HepG2_p53Act_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_p53Act_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_p53Act_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""dna binding"" intended target family, where the subfamily is ""tumor suppressor"". Is this molecule effective to this assay?",train
25,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6240121580547111,"APR_HepG2_p53Act_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_p53Act_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_p53Act_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""dna binding"" intended target family, where the subfamily is ""tumor suppressor"". Is this molecule effective to this assay?",train
26,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7127016129032258,"ATG_AP_1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_AP_1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
27,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4685482115649713,"ATG_AP_1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_AP_1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_AP_1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOS and JUN. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
28,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5411457361448031,"ATG_AP_2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_AP_2_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
29,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5964566929133859,"ATG_AP_2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_AP_2_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_AP_2_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TFAP2A and TFAP2B and TFAP2D. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-turn-helix leucine zipper. Is this molecule effective to this assay?",train
30,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6594488188976377,"ATG_AR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_AR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
31,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5266932270916335,"ATG_AR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_AR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_AR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
32,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4752155172413792,"ATG_Ahr_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Ahr_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
33,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6439805825242718,"ATG_Ahr_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Ahr_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Ahr_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AHR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein. Is this molecule effective to this assay?",train
34,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6239316239316238,"ATG_BRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_BRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
35,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5202327426606719,"ATG_BRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_BRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_BRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SMAD1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is Smad protein. Is this molecule effective to this assay?",train
36,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.689142133586578,"ATG_CAR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_CAR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
37,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5059760956175299,"ATG_CAR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_CAR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_CAR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
38,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6847677595628414,"ATG_CMV_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_CMV_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
39,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5033163265306122,"ATG_CMV_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_CMV_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_CMV_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
40,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3675889328063241,"ATG_CRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_CRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
41,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4831304024537596,"ATG_CRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_CRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_CRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CREB3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
42,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5166666666666666,"ATG_C_EBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_C_EBP_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
43,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4801551389786684,"ATG_C_EBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_C_EBP_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_C_EBP_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CEBPB. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
44,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5671887291711364,"ATG_DR4_LXR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_DR4_LXR_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
45,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3561507936507936,"ATG_DR4_LXR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_DR4_LXR_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_DR4_LXR_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2 and NR1H3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
46,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5670731707317073,"ATG_DR5_RAR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_DR5_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
47,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5058823529411764,"ATG_DR5_RAR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_DR5_RAR_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_DR5_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA and RARB and RARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
48,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6457916944259383,"ATG_E2F_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_E2F_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
49,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5436507936507936,"ATG_E2F_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_E2F_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_E2F_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene E2F1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is E2F transcription factor. Is this molecule effective to this assay?",train
50,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5793001841620626,"ATG_EGR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_EGR_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_EGR_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene EGR1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
51,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7651155428933207,"ATG_ERE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ERE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
52,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4353109903381643,"ATG_ERE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_ERE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_ERE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
53,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4374501992031873,"ATG_ERRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ERRa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
54,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4429133858267716,"ATG_ERRg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ERRg_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
55,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5254901960784314,"ATG_ERRg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_ERRg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_ERRg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESRRG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
56,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4417005879692446,"ATG_ERa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_ERa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_ERa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
57,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6082554517133957,"ATG_E_Box_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_E_Box_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
58,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6182926829268293,"ATG_E_Box_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_E_Box_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_E_Box_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene USF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein. Is this molecule effective to this assay?",train
59,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4998327759197324,"ATG_Ets_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Ets_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
60,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9137254901960784,"ATG_Ets_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Ets_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Ets_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ETS1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is winged helix-turn-helix. Is this molecule effective to this assay?",train
61,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5617529880478087,"ATG_FXR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_FXR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_FXR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
62,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5253333333333334,"ATG_FoxA2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_FoxA2_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
63,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5901639344262295,"ATG_FoxA2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_FoxA2_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_FoxA2_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXA2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein. Is this molecule effective to this assay?",train
64,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5711951447245565,"ATG_FoxO_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_FoxO_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
65,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2980392156862745,"ATG_FoxO_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_FoxO_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_FoxO_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXO1 and FOXO3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein. Is this molecule effective to this assay?",train
66,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5824120603015075,"ATG_GAL4_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GAL4_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
67,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4419294990723562,"ATG_GATA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GATA_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
68,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5885826771653544,"ATG_GATA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GATA_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GATA_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GATA1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is GATA proteins. Is this molecule effective to this assay?",train
69,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5810276679841897,"ATG_GLI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GLI_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
70,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4296814296814297,"ATG_GLI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GLI_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GLI_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GLI1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
71,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4526041666666667,"ATG_GRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
72,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5605278255880666,"ATG_GRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
73,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4265873015873015,"ATG_GR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
74,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7913306451612904,"ATG_GR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
75,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.571498892444007,"ATG_HIF1a_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HIF1a_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
76,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5718679330619629,"ATG_HIF1a_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HIF1a_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HIF1a_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HIF1A. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein. Is this molecule effective to this assay?",train
77,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7657370517928286,"ATG_HNF4a_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HNF4a_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
78,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5396825396825397,"ATG_HNF4a_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HNF4a_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HNF4a_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HNF4A. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
79,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6970766129032258,"ATG_HNF6_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HNF6_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
80,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2635046113306982,"ATG_HNF6_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HNF6_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HNF6_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ONECUT1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is homeobox protein. Is this molecule effective to this assay?",train
81,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6910569105691057,"ATG_HSE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HSE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
82,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5148809523809523,"ATG_HSE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HSE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HSE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HSF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein. Is this molecule effective to this assay?",train
83,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5589646464646465,"ATG_IR1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_IR1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
84,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5736549165120594,"ATG_IR1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_IR1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_IR1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
85,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5641156462585033,"ATG_ISRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ISRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
86,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7938508064516129,"ATG_LXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_LXRa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
87,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4842896174863388,"ATG_LXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_LXRa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_LXRa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
88,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5215686274509803,"ATG_LXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_LXRb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
89,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3948087431693989,"ATG_LXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_LXRb_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_LXRb_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
90,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4829128074097732,"ATG_MRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_MRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_MRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MTF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
91,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6862745098039216,"ATG_M_06_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_06_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_06_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
92,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4381466486729645,"ATG_M_19_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_19_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
93,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.640625,"ATG_M_19_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_19_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
94,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4352941176470588,"ATG_M_19_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_19_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_19_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
95,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5783926218708828,"ATG_M_32_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_32_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
96,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4127490039840638,"ATG_M_32_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_32_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_32_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
97,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2868525896414343,"ATG_M_32_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_32_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
98,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8759920634920635,"ATG_M_32_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_32_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_32_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
99,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7333333333333334,"ATG_M_61_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_61_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_61_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
100,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5881147540983607,"ATG_Myb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Myb_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
101,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6358565737051793,"ATG_Myb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Myb_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Myb_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYB. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is MYB proteins. Is this molecule effective to this assay?",train
102,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8998015873015873,"ATG_Myc_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Myc_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
103,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4717553688141923,"ATG_Myc_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Myc_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Myc_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYC. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper. Is this molecule effective to this assay?",train
104,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7493333333333334,"ATG_NFI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NFI_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
105,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4755859374999999,"ATG_NFI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NFI_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NFI_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFIA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear factor I. Is this molecule effective to this assay?",train
106,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6267509215376513,"ATG_NF_kB_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NF_kB_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
107,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4384298828743273,"ATG_NF_kB_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NF_kB_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NF_kB_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFKB1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B. Is this molecule effective to this assay?",train
108,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.653106922933383,"ATG_NRF1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NRF1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
109,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4453441295546558,"ATG_NRF1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NRF1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NRF1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NRF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear respiratory factors. Is this molecule effective to this assay?",train
110,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8129117259552042,"ATG_NRF2_ARE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NRF2_ARE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
111,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4830556075641265,"ATG_NRF2_ARE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NRF2_ARE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NRF2_ARE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFE2L2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
112,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5085638998682477,"ATG_NURR1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NURR1_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
113,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6314083080040527,"ATG_NURR1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NURR1_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NURR1_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR4A2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
114,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2244094488188976,"ATG_Oct_MLP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Oct_MLP_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
115,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4939418123775665,"ATG_Oct_MLP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Oct_MLP_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Oct_MLP_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene POU2F1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is POU domain protein. Is this molecule effective to this assay?",train
116,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6428571428571429,"ATG_PBREM_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PBREM_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
117,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.536682615629984,"ATG_PBREM_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PBREM_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PBREM_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
118,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.740079365079365,"ATG_PPARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PPARa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
119,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5706180344478218,"ATG_PPARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPARa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPARa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
120,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4756972111553785,"ATG_PPARd_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPARd_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPARd_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARD. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
121,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5792298570804468,"ATG_PPARg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPARg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPARg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
122,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7350649350649351,"ATG_PPRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PPRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
123,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5662249089359064,"ATG_PPRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA and PPARD and PPARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
124,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.555921052631579,"ATG_PXRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PXRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
125,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4895441651823999,"ATG_PXRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PXRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PXRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
126,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7125984251968505,"ATG_PXR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PXR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
127,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.569302615193026,"ATG_PXR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PXR_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_PXR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
128,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5937172774869109,"ATG_Pax6_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Pax6_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Pax6_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PAX6. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is paired box protein. Is this molecule effective to this assay?",train
129,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6051521208083499,"ATG_RARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RARa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
130,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5761752399704652,"ATG_RARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RARa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RARa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
131,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6166666666666667,"ATG_RARb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RARb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
132,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5609561752988048,"ATG_RARb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RARb_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RARb_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARB. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
133,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5846666666666667,"ATG_RARg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RARg_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
134,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5820962663067926,"ATG_RARg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RARg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RARg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
135,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7529411764705882,"ATG_RORE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RORE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
136,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5634352635003252,"ATG_RORE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RORE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RORE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORA and RORB and RORC. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
137,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6964143426294821,"ATG_RORb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RORb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
138,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5968379446640316,"ATG_RORg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RORg_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
139,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.615686274509804,"ATG_RORg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RORg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RORg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORC. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
140,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3464566929133858,"ATG_RXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RXRa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
141,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7212301587301587,"ATG_RXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RXRa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RXRa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
142,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.56,"ATG_RXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RXRb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
143,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5131268436578171,"ATG_RXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RXRb_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_RXRb_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
144,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4677206851119895,"ATG_SREBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_SREBP_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
145,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5730305578917858,"ATG_SREBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_SREBP_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_SREBP_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SREBF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper. Is this molecule effective to this assay?",train
146,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.484230055658627,"ATG_STAT3_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_STAT3_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
147,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2374501992031872,"ATG_STAT3_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_STAT3_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_STAT3_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene STAT3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein. Is this molecule effective to this assay?",train
148,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5823451910408433,"ATG_Sox_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Sox_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
149,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4807830459770115,"ATG_Sox_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Sox_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Sox_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SOX1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein. Is this molecule effective to this assay?",train
150,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3491436100131752,"ATG_Sp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Sp1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
151,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4967296063186474,"ATG_Sp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Sp1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Sp1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SP1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
152,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5390243902439024,"ATG_TAL_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TAL_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
153,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6403688524590163,"ATG_TAL_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TAL_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TAL_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
154,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6240157480314961,"ATG_TA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TA_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
155,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6363636363636364,"ATG_TA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TA_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TA_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
156,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.614828528607952,"ATG_TCF_b_cat_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TCF_b_cat_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
157,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4488188976377953,"ATG_TCF_b_cat_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TCF_b_cat_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TCF_b_cat_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TCF7 and TCF7L2 and LEF1 and TCF7L1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein. Is this molecule effective to this assay?",train
158,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.51731893837157,"ATG_TGFb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TGFb_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
159,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5596757852077001,"ATG_TGFb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TGFb_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TGFb_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TGFB1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta. Is this molecule effective to this assay?",train
160,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6844621513944223,"ATG_THRa1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_THRa1_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
161,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4588541666666667,"ATG_THRa1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_THRa1_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_THRa1_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene THRA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
162,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.574250138011409,"ATG_VDRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_VDRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_VDRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
163,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7047244094488188,"ATG_VDR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_VDR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
164,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7473333333333334,"ATG_VDR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_VDR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_VDR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
165,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5259259259259259,"ATG_XTT_Cytotoxicity, is one of one assay component(s) measured or calculated from the ATG_XTT_Cytotoxicity assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by XTT cytotoxicity assay technology.Data from the assay component ATG_XTT_Cytotoxicity was analyzed into 1 assay endpoint. This assay endpoint, ATG_XTT_Cytotoxicity_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
166,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5098425196850394,"ATG_Xbp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Xbp1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
167,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.520414673046252,"ATG_Xbp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Xbp1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Xbp1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene XBP1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
168,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5827770360480641,"ATG_p53_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_p53_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
169,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4279977051061389,"ATG_p53_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_p53_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_p53_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TP53. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor. Is this molecule effective to this assay?",train
170,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.481651376146789,"BSK_3C_Eselectin is an assay component measured in the BSK_3C assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Eselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
171,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.485930735930736,"BSK_3C_HLADR is an assay component measured in the BSK_3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_HLADR was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_HLADR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""MHC Class II"". Is this molecule effective to this assay?",train
172,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5482993197278911,"BSK_3C_ICAM1 is an assay component measured in the BSK_3C assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_ICAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_ICAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
173,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4734402852049911,"BSK_3C_IL8 is an assay component measured in the BSK_3C assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
174,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4568627450980392,"BSK_3C_MCP1 is an assay component measured in the BSK_3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
175,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5530679933665008,"BSK_3C_MIG is an assay component measured in the BSK_3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
176,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5338589981447124,"BSK_3C_Proliferation is an assay component measured in the BSK_3C assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.Data from the assay component BSK_3C_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_3C_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
177,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4702719797596457,"BSK_3C_SRB is an assay component measured in the BSK_3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_3C_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_3C_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
178,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4831223628691983,"BSK_3C_Thrombomodulin is an assay component measured in the BSK_3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Thrombomodulin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
179,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5054744525547445,"BSK_3C_Thrombomodulin is an assay component measured in the BSK_3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Thrombomodulin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
180,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4838167297183691,"BSK_3C_TissueFactor is an assay component measured in the BSK_3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_TissueFactor_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
181,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6864035087719298,"BSK_3C_TissueFactor is an assay component measured in the BSK_3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_TissueFactor_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
182,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4875950380152061,"BSK_3C_VCAM1 is an assay component measured in the BSK_3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
183,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5296740994854202,"BSK_3C_Vis is an assay component measured in the BSK_3C assay. It measures NA related to cell morphology using light microscopy technology.Data from the assay component BSK_3C_Vis was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Vis_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, loss-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
184,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4948717948717949,"BSK_3C_uPAR is an assay component measured in the BSK_3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
185,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4960119641076769,"BSK_4H_Eotaxin3 is an assay component measured in the BSK_4H assay. It measures Eotaxin-3 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_Eotaxin3 was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_Eotaxin3_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL26. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
186,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4731292517006802,"BSK_4H_MCP1 is an assay component measured in the BSK_4H assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
187,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4903061224489796,"BSK_4H_Pselectin is an assay component measured in the BSK_4H assay. It measures P-Selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_Pselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_Pselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELP. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
188,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7040816326530612,"BSK_4H_Pselectin is an assay component measured in the BSK_4H assay. It measures P-Selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_Pselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_Pselectin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELP. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
189,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.468362905925678,"BSK_4H_SRB is an assay component measured in the BSK_4H assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_4H_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_4H_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
190,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.513893653516295,"BSK_4H_VCAM1 is an assay component measured in the BSK_4H assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
191,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4938235294117646,"BSK_4H_VEGFRII is an assay component measured in the BSK_4H assay. It measures VEGFRII antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_VEGFRII was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_VEGFRII_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
192,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5215686274509803,"BSK_4H_uPAR is an assay component measured in the BSK_4H assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
193,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6163522012578616,"BSK_4H_uPAR is an assay component measured in the BSK_4H assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_uPAR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
194,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5427392739273927,"BSK_BE3C_HLADR is an assay component measured in the BSK_BE3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_HLADR was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_HLADR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""MHC Class II"". Is this molecule effective to this assay?",train
195,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5798981009726725,"BSK_BE3C_IL1a is an assay component measured in the BSK_BE3C assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_IL1a_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
196,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5284050811573747,"BSK_BE3C_IP10 is an assay component measured in the BSK_BE3C assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_IP10_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
197,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6205692803437165,"BSK_BE3C_MIG is an assay component measured in the BSK_BE3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
198,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5591176470588235,"BSK_BE3C_MMP1 is an assay component measured in the BSK_BE3C assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_MMP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
199,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5678104575163399,"BSK_BE3C_MMP1 is an assay component measured in the BSK_BE3C assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_MMP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
200,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4970501474926253,"BSK_BE3C_PAI1 is an assay component measured in the BSK_BE3C assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_PAI1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_PAI1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator inhibitor"". Is this molecule effective to this assay?",train
201,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4952380952380952,"BSK_BE3C_SRB is an assay component measured in the BSK_BE3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_BE3C_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_BE3C_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
202,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5867248062015504,"BSK_BE3C_TGFb1 is an assay component measured in the BSK_BE3C assay. It measures TGF-b1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_TGFb1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_TGFb1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""growth factor"" intended target family, where the subfamily is ""transforming growth factor beta"". Is this molecule effective to this assay?",train
203,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5397727272727273,"BSK_BE3C_tPA is an assay component measured in the BSK_BE3C assay. It measures tPA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_tPA was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_tPA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAT. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
204,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5697674418604651,"BSK_BE3C_uPAR is an assay component measured in the BSK_BE3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
205,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1898734177215189,"BSK_BE3C_uPAR is an assay component measured in the BSK_BE3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_uPAR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
206,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5564049586776859,"BSK_BE3C_uPA is an assay component measured in the BSK_BE3C assay. It measures uPA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_uPA was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_uPA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
207,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5539152759948651,"BSK_CASM3C_HLADR is an assay component measured in the BSK_CASM3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_HLADR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_HLADR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""MHC Class II"". Is this molecule effective to this assay?",train
208,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5502148227712138,"BSK_CASM3C_IL6 is an assay component measured in the BSK_CASM3C assay. It measures IL-6 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_IL6 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_IL6_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
209,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6307977736549165,"BSK_CASM3C_IL6 is an assay component measured in the BSK_CASM3C assay. It measures IL-6 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_IL6 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_IL6_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
210,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4799836601307189,"BSK_CASM3C_IL8 is an assay component measured in the BSK_CASM3C assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
211,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5059861373660995,"BSK_CASM3C_LDLR is an assay component measured in the BSK_CASM3C assay. It measures LDLR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_LDLR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_LDLR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene LDLR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""misc protein"" intended target family, where the subfamily is ""LDL receptor"". Is this molecule effective to this assay?",train
212,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6890184645286687,"BSK_CASM3C_LDLR is an assay component measured in the BSK_CASM3C assay. It measures LDLR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_LDLR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_LDLR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene LDLR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""misc protein"" intended target family, where the subfamily is ""LDL receptor"". Is this molecule effective to this assay?",train
213,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4992555831265508,"BSK_CASM3C_MCP1 is an assay component measured in the BSK_CASM3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
214,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7515923566878981,"BSK_CASM3C_MCP1 is an assay component measured in the BSK_CASM3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
215,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4914772727272727,"BSK_CASM3C_MCSF is an assay component measured in the BSK_CASM3C assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCSF_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
216,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7898089171974522,"BSK_CASM3C_MCSF is an assay component measured in the BSK_CASM3C assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCSF_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
217,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5641025641025641,"BSK_CASM3C_MIG is an assay component measured in the BSK_CASM3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
218,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.521283255086072,"BSK_CASM3C_Proliferation is an assay component measured in the BSK_CASM3C assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.Data from the assay component BSK_CASM3C_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_CASM3C_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
219,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4955882352941176,"BSK_CASM3C_SAA is an assay component measured in the BSK_CASM3C assay. It measures SAA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_SAA was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_SAA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""apolipoproteins"". Is this molecule effective to this assay?",train
220,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9375,"BSK_CASM3C_SAA is an assay component measured in the BSK_CASM3C assay. It measures SAA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_SAA was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_SAA_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""apolipoproteins"". Is this molecule effective to this assay?",train
221,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5406976744186046,"BSK_CASM3C_SRB is an assay component measured in the BSK_CASM3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_CASM3C_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_CASM3C_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
222,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5418181818181818,"BSK_CASM3C_Thrombomodulin is an assay component measured in the BSK_CASM3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_Thrombomodulin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
223,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4558638083228247,"BSK_CASM3C_Thrombomodulin is an assay component measured in the BSK_CASM3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_Thrombomodulin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
224,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5304136253041363,"BSK_CASM3C_TissueFactor is an assay component measured in the BSK_CASM3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_TissueFactor_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
225,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5076923076923077,"BSK_CASM3C_VCAM1 is an assay component measured in the BSK_CASM3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
226,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4387755102040816,"BSK_CASM3C_VCAM1 is an assay component measured in the BSK_CASM3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_VCAM1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
227,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.555871212121212,"BSK_CASM3C_uPAR is an assay component measured in the BSK_CASM3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
228,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4,"BSK_CASM3C_uPAR is an assay component measured in the BSK_CASM3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_uPAR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
229,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6481481481481483,"BSK_KF3CT_ICAM1 is an assay component measured in the BSK_KF3CT assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_ICAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_ICAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
230,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6267573696145124,"BSK_KF3CT_IL1a is an assay component measured in the BSK_KF3CT assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_IL1a_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
231,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5418066442702502,"BSK_KF3CT_IP10 is an assay component measured in the BSK_KF3CT assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_IP10_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
232,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5153846153846153,"BSK_KF3CT_IP10 is an assay component measured in the BSK_KF3CT assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_IP10_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
233,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5499999999999999,"BSK_KF3CT_MCP1 is an assay component measured in the BSK_KF3CT assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
234,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3923076923076923,"BSK_KF3CT_MCP1 is an assay component measured in the BSK_KF3CT assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_MCP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
235,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5256684491978609,"BSK_KF3CT_MMP9 is an assay component measured in the BSK_KF3CT assay. It measures MMP-9 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_MMP9 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_MMP9_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
236,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6499477533960293,"BSK_KF3CT_SRB is an assay component measured in the BSK_KF3CT assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_KF3CT_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_KF3CT_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
237,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6324444444444445,"BSK_KF3CT_TGFb1 is an assay component measured in the BSK_KF3CT assay. It measures TGF-b1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_TGFb1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_TGFb1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""growth factor"" intended target family, where the subfamily is ""transforming growth factor beta"". Is this molecule effective to this assay?",train
238,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6610586011342154,"BSK_KF3CT_TIMP2 is an assay component measured in the BSK_KF3CT assay. It measures TIMP-2 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_TIMP2 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_TIMP2_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease inhibitor"" intended target family, where the subfamily is ""metalloproteinase inhibitor"". Is this molecule effective to this assay?",train
239,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6843672456575683,"BSK_KF3CT_uPA is an assay component measured in the BSK_KF3CT assay. It measures uPA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_uPA was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_uPA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
240,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5189152996317375,"BSK_LPS_CD40 is an assay component measured in the BSK_LPS assay. It measures CD40 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_CD40 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_CD40_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
241,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4584304584304584,"BSK_LPS_Eselectin is an assay component measured in the BSK_LPS assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_Eselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
242,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7426160337552742,"BSK_LPS_Eselectin is an assay component measured in the BSK_LPS assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_Eselectin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
243,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5842336934773911,"BSK_LPS_IL1a is an assay component measured in the BSK_LPS assay. It measures IL-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL1a_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
244,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3694267515923567,"BSK_LPS_IL1a is an assay component measured in the BSK_LPS assay. It measures IL-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL1a_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
245,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4605363984674329,"BSK_LPS_IL8 is an assay component measured in the BSK_LPS assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
246,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5311827956989248,"BSK_LPS_IL8 is an assay component measured in the BSK_LPS assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL8_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
247,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4823008849557522,"BSK_LPS_MCP1 is an assay component measured in the BSK_LPS assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
248,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5112914608327452,"BSK_LPS_MCSF is an assay component measured in the BSK_LPS assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_MCSF_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
249,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5330484330484331,"BSK_LPS_PGE2 is an assay component measured in the BSK_LPS assay. It measures PGE2 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_PGE2 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_PGE2_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PTGER2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
250,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.35,"BSK_LPS_PGE2 is an assay component measured in the BSK_LPS assay. It measures PGE2 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_PGE2 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_PGE2_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PTGER2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
251,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4917977904251758,"BSK_LPS_SRB is an assay component measured in the BSK_LPS assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_LPS_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_LPS_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
252,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5722992854140394,"BSK_LPS_TNFa is an assay component measured in the BSK_LPS assay. It measures TNF-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TNFa was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TNFa_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TNF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
253,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3300415800415801,"BSK_LPS_TNFa is an assay component measured in the BSK_LPS assay. It measures TNF-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TNFa was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TNFa_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene TNF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
254,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.561323155216285,"BSK_LPS_TissueFactor is an assay component measured in the BSK_LPS assay. It measures CD142 Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TissueFactor_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
255,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6927152317880795,"BSK_LPS_TissueFactor is an assay component measured in the BSK_LPS assay. It measures CD142 Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TissueFactor_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
256,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4799238490827276,"BSK_LPS_VCAM1 is an assay component measured in the BSK_LPS assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
257,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4676236044657097,"BSK_SAg_CD38, is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.Data from the assay component BSK_SAg_CD38 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_CD38_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD38. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""other cytokine"". Is this molecule effective to this assay?",train
258,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5017628205128205,"BSK_SAg_CD40, is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.Data from the assay component BSK_SAg_CD40 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_CD40_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
259,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4882409793814433,"BSK_SAg_CD69, is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.Data from the assay component BSK_SAg_CD69 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_CD69_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD69. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
260,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4433962264150943,"BSK_SAg_Eselectin is an assay component measured in the BSK_SAg assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_Eselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
261,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6920529801324503,"BSK_SAg_Eselectin is an assay component measured in the BSK_SAg assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_Eselectin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
262,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.45317055393586,"BSK_SAg_IL8 is an assay component measured in the BSK_SAg assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
263,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7463576158940397,"BSK_SAg_IL8 is an assay component measured in the BSK_SAg assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_IL8_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
264,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4515117994100295,"BSK_SAg_MCP1 is an assay component measured in the BSK_SAg assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
265,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4229024943310657,"BSK_SAg_MIG is an assay component measured in the BSK_SAg assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
266,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4800453514739229,"BSK_SAg_PBMCCytotoxicity is an assay component measured in the BSK_SAg assay. It measures Alamar blue related to cell death using Alamar Blue Reduction technology.Data from the assay component BSK_SAg_PBMCCytotoxicity was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_PBMCCytotoxicity_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""proliferation"". Is this molecule effective to this assay?",train
267,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3955296404275996,"BSK_SAg_PBMCCytotoxicity is an assay component measured in the BSK_SAg assay. It measures Alamar blue related to cell death using Alamar Blue Reduction technology.Data from the assay component BSK_SAg_PBMCCytotoxicity was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_PBMCCytotoxicity_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
268,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5251543209876544,"BSK_SAg_Proliferation is an assay component in the BSK_SAg assay. It measures protein content, a form of viability reporter, as detected with absorbance signals by Sulforhodamine staining technology. Data from the assay component BSK_SAg_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_SAg_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
269,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.505229419703104,"BSK_SAg_SRB is an assay component measured in the BSK_SAg assay. It measures protein content, a form of viability reporter, as detected with absorbance signals by Sulforhodamine staining technology.Data from the assay component BSK_SAg_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_SAg_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
270,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4362334032145352,"BSK_hDFCGF_CollagenIII is an assay component measured in the BSK_hDFCGF assay. It measures Collagen antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_CollagenIII was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_CollagenIII_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene COL3A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""collagen"". Is this molecule effective to this assay?",train
271,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4782608695652174,"BSK_hDFCGF_EGFR is an assay component measured in the BSK_hDFCGF assay. It measures EGFR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_EGFR was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_EGFR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
272,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.556989247311828,"BSK_hDFCGF_EGFR is an assay component measured in the BSK_hDFCGF assay. It measures EGFR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_EGFR was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_EGFR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
273,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5174129353233831,"BSK_hDFCGF_IL8 is an assay component measured in the BSK_hDFCGF assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
274,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5381461675579322,"BSK_hDFCGF_IP10 is an assay component measured in the BSK_hDFCGF assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_IP10_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
275,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5133264105226722,"BSK_hDFCGF_MCSF is an assay component measured in the BSK_hDFCGF assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MCSF_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
276,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5742404792468978,"BSK_hDFCGF_MIG is an assay component measured in the BSK_hDFCGF assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
277,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5067255149222363,"BSK_hDFCGF_MMP1 is an assay component measured in the BSK_hDFCGF assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MMP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
278,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3304635761589404,"BSK_hDFCGF_MMP1 is an assay component measured in the BSK_hDFCGF assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MMP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
279,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5049319727891157,"BSK_hDFCGF_PAI1 is an assay component measured in the BSK_hDFCGF assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_PAI1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_PAI1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator inhibitor"". Is this molecule effective to this assay?",train
280,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4737411183194316,"BSK_hDFCGF_Proliferation is an assay component measured in the BSK_hDFCGF assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.Data from the assay component BSK_hDFCGF_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_hDFCGF_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
281,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4787234042553191,"BSK_hDFCGF_SRB is an assay component measured in the BSK_hDFCGF assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_hDFCGF_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_hDFCGF_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
282,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5726799242424242,"BSK_hDFCGF_TIMP1 is an assay component measured in the BSK_hDFCGF assay. It measures TIMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_TIMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_TIMP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease inhibitor"" intended target family, where the subfamily is ""metalloproteinase inhibitor"". Is this molecule effective to this assay?",train
283,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.493885394828791,"BSK_hDFCGF_VCAM1 is an assay component measured in the BSK_hDFCGF assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
284,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.59375,"CEETOX_H295R_11DCORT, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_11DCORT was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_11DCORT_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 11-Deoxycortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
285,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5160984848484849,"CEETOX_H295R_ANDR, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ANDR was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ANDR_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Androstenedione in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens. Is this molecule effective to this assay?",train
286,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4576744186046512,"CEETOX_H295R_CORTISOL, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_CORTISOL was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_CORTISOL_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Cortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
287,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6046511627906976,"CEETOX_H295R_DOC, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_DOC was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_DOC_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
288,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5641646489104116,"CEETOX_H295R_DOC, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_DOC was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_DOC_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
289,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3916666666666666,"CEETOX_H295R_ESTRADIOL, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRADIOL was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRADIOL_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
290,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4894613583138173,"CEETOX_H295R_ESTRADIOL, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRADIOL was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRADIOL_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
291,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4030131826741996,"CEETOX_H295R_ESTRONE, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRONE was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRONE_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estrone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
292,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1904761904761904,"CEETOX_H295R_ESTRONE, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRONE was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRONE_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estrone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
293,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4023323615160349,"CEETOX_H295R_OHPREG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_OHPREG_up was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_OHPREG_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxypregnenolone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
294,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5038461538461538,"CEETOX_H295R_OHPROG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_OHPROG was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_OHPROG_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
295,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6042884990253412,"CEETOX_H295R_OHPROG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_OHPROG_up was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_OHPROG_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
296,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6270903010033444,"CEETOX_H295R_PROG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_PROG was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_PROG_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Progesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
297,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4173913043478261,"CEETOX_H295R_TESTO, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_TESTO was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_TESTO_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Testosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens. Is this molecule effective to this assay?",train
298,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5611111111111111,"CLD_ABCB1_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_ABCB1_48hr was analyzed at the endpoint, CLD_ABCB1_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter. Is this molecule effective to this assay?",train
299,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3166666666666666,"CLD_ABCG2_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_ABCG2_48hr was analyzed at the endpoint, CLD_ABCG2_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCG2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter. Is this molecule effective to this assay?",train
300,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6733212341197822,"CLD_CYP1A1_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A1_24hr was analyzed at the endpoint, CLD_CYP1A1_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
301,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6569872958257712,"CLD_CYP1A1_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A1_48hr was analyzed at the endpoint, CLD_CYP1A1_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
302,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6591836734693878,"CLD_CYP1A1_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A1_6hr was analyzed at the endpoint, CLD_CYP1A1_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
303,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4797979797979798,"CLD_CYP1A2_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A2_24hr was analyzed at the endpoint, CLD_CYP1A2_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
304,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5555555555555555,"CLD_CYP1A2_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A2_48hr was analyzed at the endpoint, CLD_CYP1A2_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
305,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6688034188034188,"CLD_CYP1A2_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A2_6hr was analyzed at the endpoint, CLD_CYP1A2_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
306,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6921768707482994,"CLD_CYP2B6_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP2B6_24hr was analyzed at the endpoint, CLD_CYP2B6_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
307,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7006688963210702,"CLD_CYP2B6_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP2B6_48hr was analyzed at the endpoint, CLD_CYP2B6_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
308,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6842105263157895,"CLD_CYP2B6_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP2B6_6hr was analyzed at the endpoint, CLD_CYP2B6_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
309,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5888888888888889,"CLD_CYP3A4_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP3A4_24hr was analyzed at the endpoint, CLD_CYP3A4_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
310,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6890909090909091,"CLD_CYP3A4_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP3A4_48hr was analyzed at the endpoint, CLD_CYP3A4_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
311,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6609686609686609,"CLD_CYP3A4_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP3A4_6hr was analyzed at the endpoint, CLD_CYP3A4_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
312,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5681818181818181,"CLD_GSTA2_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_GSTA2_48hr was analyzed at the endpoint, CLD_GSTA2_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GSTA2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is alkyl and aryl transferase. Is this molecule effective to this assay?",train
313,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5,"CLD_SULT2A_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_SULT2A_24hr was analyzed at the endpoint, CLD_SULT2A_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase. Is this molecule effective to this assay?",train
314,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5247747747747747,"CLD_SULT2A_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_SULT2A_48hr was analyzed at the endpoint, CLD_SULT2A_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase. Is this molecule effective to this assay?",train
315,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.521341463414634,"CLD_UGT1A1_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_UGT1A1_24hr was analyzed at the endpoint, CLD_UGT1A1_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase. Is this molecule effective to this assay?",train
316,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6705426356589148,"CLD_UGT1A1_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_UGT1A1_48hr was analyzed at the endpoint, CLD_UGT1A1_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase. Is this molecule effective to this assay?",train
317,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5789473684210527,"NVS_ADME_hCYP19A1, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP19A1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP19A1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP19A1, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP19A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""steroidogenesis-related"". Is this molecule effective to this assay?",train
318,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6416666666666667,"NVS_ADME_hCYP1A1, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP1A1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP1A1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP1A1, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP1A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
319,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5499999999999999,"NVS_ADME_hCYP1A2, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP1A2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP1A2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP1A2, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP1A2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
320,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.25,"NVS_ADME_hCYP2A6, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2A6 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2A6 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2A6, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2A6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
321,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4615384615384615,"NVS_ADME_hCYP2B6, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2B6 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2B6 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2B6, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2B6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
322,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5145067698259188,"NVS_ADME_hCYP2C19, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2C19 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2C19 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2C19, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C19. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
323,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3862068965517241,"NVS_ADME_hCYP2C9, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2C9 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2C9 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2C9, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
324,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6181818181818182,"NVS_ADME_hCYP2D6, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2D6 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2D6 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2D6, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2D6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
325,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5066666666666666,"NVS_ADME_hCYP3A4, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP3A4 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP3A4 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP3A4, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP3A4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
326,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8,"NVS_ADME_rCYP2C12, is one of one assay component(s) measured or calculated from the NVS_ADME_rCYP2C12 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_rCYP2C12 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_rCYP2C12, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2c12. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
327,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.787878787878788,"NVS_ENZ_hAChE, is one of one assay component(s) measured or calculated from the NVS_ENZ_hAChE assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_hAChE was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hAChE, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ACHE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""acetylcholinesterase"". Is this molecule effective to this assay?",train
328,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_ENZ_hAMPKa1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hAMPKa1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hAMPKa1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hAMPKa1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PRKAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
329,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3076923076923076,"NVS_ENZ_hAurA, is one of one assay component(s) measured or calculated from the NVS_ENZ_hAurA assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hAurA was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hAurA, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene AURKA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
330,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7603305785123967,"NVS_ENZ_hBACE, is one of one assay component(s) measured or calculated from the NVS_ENZ_hBACE assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hBACE was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hBACE, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene BACE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""aspartate protease"". Is this molecule effective to this assay?",train
331,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_ENZ_hCASP5, is one of one assay component(s) measured or calculated from the NVS_ENZ_hCASP5 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hCASP5 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hCASP5, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""cysteine protease"". Is this molecule effective to this assay?",train
332,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2727272727272727,"NVS_ENZ_hCK1D, is one of one assay component(s) measured or calculated from the NVS_ENZ_hCK1D assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hCK1D was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hCK1D, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CSNK1D. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
333,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8395061728395062,"NVS_ENZ_hDUSP3, is one of one assay component(s) measured or calculated from the NVS_ENZ_hDUSP3 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hDUSP3 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hDUSP3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene DUSP3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""dual-specific phosphatase"". Is this molecule effective to this assay?",train
334,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6000000000000001,"NVS_ENZ_hES, is one of one assay component(s) measured or calculated from the NVS_ENZ_hES assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_hES was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hES, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene BCHE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""pseudocholinesterase"". Is this molecule effective to this assay?",train
335,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6904761904761905,"NVS_ENZ_hElastase, is one of one assay component(s) measured or calculated from the NVS_ENZ_hElastase assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Spectrophotometry technology.Data from the assay component NVS_ENZ_hElastase was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hElastase, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ELANE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
336,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2380952380952381,"NVS_ENZ_hFGFR1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hFGFR1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hFGFR1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hFGFR1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene FGFR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
337,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4736842105263158,"NVS_ENZ_hGSK3b, is one of one assay component(s) measured or calculated from the NVS_ENZ_hGSK3b assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hGSK3b was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hGSK3b, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene GSK3B. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
338,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2857142857142857,"NVS_ENZ_hMMP1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
339,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4545454545454545,"NVS_ENZ_hMMP13, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP13 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP13 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP13, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP13. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
340,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666666,"NVS_ENZ_hMMP2, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
341,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5324675324675324,"NVS_ENZ_hMMP3, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP3 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP3 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
342,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4444444444444444,"NVS_ENZ_hMMP7, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP7 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP7 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP7, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
343,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8571428571428571,"NVS_ENZ_hMMP9, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP9 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP9 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP9, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
344,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.875,"NVS_ENZ_hPDE10, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPDE10 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPDE10 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPDE10, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE10A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""phosphodiesterase"". Is this molecule effective to this assay?",train
345,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3454545454545454,"NVS_ENZ_hPDE4A1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPDE4A1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPDE4A1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPDE4A1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE4A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""phosphodiesterase"". Is this molecule effective to this assay?",train
346,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6358024691358024,"NVS_ENZ_hPDE5, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPDE5 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPDE5 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPDE5, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE5A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""phosphodiesterase"". Is this molecule effective to this assay?",train
347,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6944444444444444,"NVS_ENZ_hPI3Ka, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPI3Ka assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPI3Ka was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPI3Ka, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PIK3CA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""phosphoinositol kinase"". Is this molecule effective to this assay?",train
348,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5777777777777778,"NVS_ENZ_hPTEN, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTEN assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTEN was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTEN, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTEN. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""dual-specific phosphatase"". Is this molecule effective to this assay?",train
349,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2222222222222222,"NVS_ENZ_hPTPN11, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN11 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN11 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN11, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN11. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
350,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1428571428571429,"NVS_ENZ_hPTPN12, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN12 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN12 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN12, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN12. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
351,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7222222222222222,"NVS_ENZ_hPTPN13, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN13 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN13 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN13, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN13. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
352,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5555555555555556,"NVS_ENZ_hPTPN9, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN9 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN9 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN9, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
353,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5714285714285714,"NVS_ENZ_hPTPRC, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPRC assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_hPTPRC was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPRC, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPRC. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
354,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5,"NVS_ENZ_hSIRT1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hSIRT1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hSIRT1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hSIRT1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SIRT1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""hydrolase"" intended target family, where the subfamily is ""protein deacetylase"". Is this molecule effective to this assay?",train
355,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3888888888888889,"NVS_ENZ_hSIRT2, is one of one assay component(s) measured or calculated from the NVS_ENZ_hSIRT2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hSIRT2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hSIRT2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SIRT2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""hydrolase"" intended target family, where the subfamily is ""protein deacetylase"". Is this molecule effective to this assay?",train
356,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.75,"NVS_ENZ_hTrkA, is one of one assay component(s) measured or calculated from the NVS_ENZ_hTrkA assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hTrkA was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hTrkA, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene NTRK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
357,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_ENZ_hVEGFR2, is one of one assay component(s) measured or calculated from the NVS_ENZ_hVEGFR2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hVEGFR2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hVEGFR2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
358,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6875,"NVS_ENZ_oCOX1, is one of one assay component(s) measured or calculated from the NVS_ENZ_oCOX1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_oCOX1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_oCOX1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTGS1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""cyclooxygenase"". Is this molecule effective to this assay?",train
359,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9545454545454546,"NVS_ENZ_oCOX2, is one of one assay component(s) measured or calculated from the NVS_ENZ_oCOX2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_oCOX2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_oCOX2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTGS2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""cyclooxygenase"". Is this molecule effective to this assay?",train
360,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.59375,"NVS_ENZ_rAChE, is one of one assay component(s) measured or calculated from the NVS_ENZ_rAChE assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_rAChE was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rAChE, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Ache. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""acetylcholinesterase"". Is this molecule effective to this assay?",train
361,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6,"NVS_ENZ_rCNOS, is one of one assay component(s) measured or calculated from the NVS_ENZ_rCNOS assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_ENZ_rCNOS was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rCNOS, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Nos1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""nitric oxide synthase"". Is this molecule effective to this assay?",train
362,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8055555555555556,"NVS_ENZ_rMAOAC, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOAC assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOAC was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOAC, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maoa. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
363,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5476190476190477,"NVS_ENZ_rMAOAP, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOAP assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOAP was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOAP, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maoa. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
364,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3454545454545454,"NVS_ENZ_rMAOBC, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOBC assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOBC was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOBC, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maob. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
365,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4285714285714286,"NVS_ENZ_rMAOBP, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOBP assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOBP was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOBP, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maob. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
366,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2727272727272727,"NVS_ENZ_rabI2C, is one of one assay component(s) measured or calculated from the NVS_ENZ_rabI2C assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_ENZ_rabI2C was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rabI2C, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CKB. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""imidazoline receptor"". Is this molecule effective to this assay?",train
367,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3636363636363636,"NVS_GPCR_bAdoR_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_bAdoR_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_bAdoR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bAdoR_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
368,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7142857142857143,"NVS_GPCR_bDR_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_bDR_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_bDR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bDR_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
369,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7912087912087913,"NVS_GPCR_g5HT4, is one of one assay component(s) measured or calculated from the NVS_GPCR_g5HT4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_g5HT4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_g5HT4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
370,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.575,"NVS_GPCR_gH2, is one of one assay component(s) measured or calculated from the NVS_GPCR_gH2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gH2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gH2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Hrh2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
371,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2499999999999999,"NVS_GPCR_gLTB4, is one of one assay component(s) measured or calculated from the NVS_GPCR_gLTB4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gLTB4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gLTB4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Ltb4r. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
372,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5833333333333333,"NVS_GPCR_gLTD4, is one of one assay component(s) measured or calculated from the NVS_GPCR_gLTD4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gLTD4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gLTD4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cysltr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
373,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.763888888888889,"NVS_GPCR_gMPeripheral_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_gMPeripheral_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gMPeripheral_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gMPeripheral_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Chrm3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
374,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6184210526315789,"NVS_GPCR_gOpiateK, is one of one assay component(s) measured or calculated from the NVS_GPCR_gOpiateK assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gOpiateK was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gOpiateK, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprk1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
375,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6428571428571428,"NVS_GPCR_h5HT2A, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT2A assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT2A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT2A, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
376,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5568181818181819,"NVS_GPCR_h5HT5A, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT5A assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT5A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT5A, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR5A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
377,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4399999999999999,"NVS_GPCR_h5HT6, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT6 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT6, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
378,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4649999999999999,"NVS_GPCR_h5HT7, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT7 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT7 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT7, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
379,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666666,"NVS_GPCR_hAT1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAT1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAT1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AGTR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
380,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7619047619047619,"NVS_GPCR_hAdoRA1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdoRA1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdoRA1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdoRA1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
381,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1666666666666666,"NVS_GPCR_hAdoRA2a, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdoRA2a assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdoRA2a was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdoRA2a, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
382,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4897959183673469,"NVS_GPCR_hAdra2A, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdra2A assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdra2A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdra2A, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRA2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
383,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4358974358974359,"NVS_GPCR_hAdra2C, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdra2C assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdra2C was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdra2C, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRA2C. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
384,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.375,"NVS_GPCR_hAdrb1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdrb1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdrb1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
385,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9393939393939392,"NVS_GPCR_hAdrb2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdrb2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdrb2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
386,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6818181818181819,"NVS_GPCR_hAdrb3, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdrb3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdrb3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
387,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5083333333333333,"NVS_GPCR_hDRD1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hDRD1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hDRD1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
388,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2777777777777777,"NVS_GPCR_hDRD2s, is one of one assay component(s) measured or calculated from the NVS_GPCR_hDRD2s assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hDRD2s was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD2s, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
389,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3703703703703703,"NVS_GPCR_hDRD4.4, is one of one assay component(s) measured or calculated from the NVS_GPCR_hDRD4.4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hDRD4.4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD4.4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
390,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7142857142857143,"NVS_GPCR_hH1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hH1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hH1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hH1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HRH1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
391,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.575,"NVS_GPCR_hLTB4_BLT1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hLTB4_BLT1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hLTB4_BLT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hLTB4_BLT1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene LTB4R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
392,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5111111111111111,"NVS_GPCR_hM1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
393,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4583333333333333,"NVS_GPCR_hM2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
394,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4272727272727272,"NVS_GPCR_hM3, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
395,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6041666666666667,"NVS_GPCR_hM4, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
396,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6761904761904762,"NVS_GPCR_hNK2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hNK2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hNK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hNK2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TACR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
397,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4761904761904761,"NVS_GPCR_hOpiate_D1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hOpiate_D1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hOpiate_D1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hOpiate_D1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene OPRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
398,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5375000000000001,"NVS_GPCR_hOpiate_mu, is one of one assay component(s) measured or calculated from the NVS_GPCR_hOpiate_mu assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hOpiate_mu was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hOpiate_mu, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene OPRM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
399,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.509090909090909,"NVS_GPCR_hTXA2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hTXA2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hTXA2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hTXA2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TBXA2R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
400,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4,"NVS_GPCR_p5HT2C, is one of one assay component(s) measured or calculated from the NVS_GPCR_p5HT2C assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_p5HT2C was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_p5HT2C, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR2C. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
401,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.44,"NVS_GPCR_r5HT1_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_r5HT1_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_r5HT1_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_r5HT1_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
402,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666666,"NVS_GPCR_r5HT_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_r5HT_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_r5HT_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_r5HT_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
403,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5740740740740741,"NVS_GPCR_rAdra1B, is one of one assay component(s) measured or calculated from the NVS_GPCR_rAdra1B assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rAdra1B was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1B, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1b. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
404,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.72,"NVS_GPCR_rAdra1_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_rAdra1_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rAdra1_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
405,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5961538461538463,"NVS_GPCR_rAdra2_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_rAdra2_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rAdra2_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra2_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra2a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
406,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6333333333333334,"NVS_GPCR_rNK1, is one of one assay component(s) measured or calculated from the NVS_GPCR_rNK1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rNK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rNK1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tacr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
407,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.575,"NVS_GPCR_rNK3, is one of one assay component(s) measured or calculated from the NVS_GPCR_rNK3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rNK3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rNK3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tacr3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
408,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6611111111111112,"NVS_GPCR_rOpiate_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_rOpiate_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rOpiate_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rOpiate_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprm1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
409,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4818181818181818,"NVS_GPCR_rOpiate_NonSelectiveNa, is one of one assay component(s) measured or calculated from the NVS_GPCR_rOpiate_NonSelectiveNa assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rOpiate_NonSelectiveNa was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rOpiate_NonSelectiveNa, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprm1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
410,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666667,"NVS_GPCR_rSST, is one of one assay component(s) measured or calculated from the NVS_GPCR_rSST assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rSST was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rSST, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Sstr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
411,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6379310344827587,"NVS_GPCR_rTRH, is one of one assay component(s) measured or calculated from the NVS_GPCR_rTRH assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rTRH was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rTRH, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Trhr. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
412,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1071428571428571,"NVS_GPCR_rV1, is one of one assay component(s) measured or calculated from the NVS_GPCR_rV1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rV1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rV1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Avpr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
413,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6190476190476192,"NVS_GPCR_rabPAF, is one of one assay component(s) measured or calculated from the NVS_GPCR_rabPAF assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rabPAF was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rabPAF, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PTAFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
414,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.55,"NVS_GPCR_rmAdra2B, is one of one assay component(s) measured or calculated from the NVS_GPCR_rmAdra2B assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rmAdra2B was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rmAdra2B, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra2b. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
415,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4363636363636363,"NVS_IC_hKhERGCh, is one of one assay component(s) measured or calculated from the NVS_IC_hKhERGCh assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_hKhERGCh was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_hKhERGCh, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene KCNH2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""potassium channel"". Is this molecule effective to this assay?",train
416,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5714285714285714,"NVS_IC_rCaBTZCHL, is one of one assay component(s) measured or calculated from the NVS_IC_rCaBTZCHL assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_rCaBTZCHL was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rCaBTZCHL, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cacna1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""calcium channel"". Is this molecule effective to this assay?",train
417,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8333333333333334,"NVS_IC_rCaDHPRCh_L, is one of one assay component(s) measured or calculated from the NVS_IC_rCaDHPRCh_L assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_rCaDHPRCh_L was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rCaDHPRCh_L, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cacna1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""calcium channel"". Is this molecule effective to this assay?",train
418,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5158730158730158,"NVS_IC_rNaCh_site2, is one of one assay component(s) measured or calculated from the NVS_IC_rNaCh_site2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_rNaCh_site2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rNaCh_site2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Scn1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""sodium channel"". Is this molecule effective to this assay?",train
419,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.525,"NVS_LGIC_bGABARa1, is one of one assay component(s) measured or calculated from the NVS_LGIC_bGABARa1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_bGABARa1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_bGABARa1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene GABRA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
420,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.875,"NVS_LGIC_h5HT3, is one of one assay component(s) measured or calculated from the NVS_LGIC_h5HT3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_h5HT3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_h5HT3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR3A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
421,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5555555555555556,"NVS_LGIC_hNNR_NBungSens, is one of one assay component(s) measured or calculated from the NVS_LGIC_hNNR_NBungSens assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_hNNR_NBungSens was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_hNNR_NBungSens, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRNA2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
422,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5416666666666667,"NVS_LGIC_rGABAR_NonSelective, is one of one assay component(s) measured or calculated from the NVS_LGIC_rGABAR_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_rGABAR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rGABAR_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Gabra1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
423,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4805194805194804,"NVS_LGIC_rNNR_BungSens, is one of one assay component(s) measured or calculated from the NVS_LGIC_rNNR_BungSens assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_rNNR_BungSens was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rNNR_BungSens, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Chrna7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
424,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.650390625,"NVS_MP_hPBR, is one of one assay component(s) measured or calculated from the NVS_MP_hPBR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_MP_hPBR was analyzed into 1 assay endpoint. This assay endpoint, NVS_MP_hPBR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TSPO. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""cholesterol transporter"". Is this molecule effective to this assay?",train
425,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7114695340501792,"NVS_MP_rPBR, is one of one assay component(s) measured or calculated from the NVS_MP_rPBR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_MP_rPBR was analyzed into 1 assay endpoint. This assay endpoint, NVS_MP_rPBR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tspo. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""cholesterol transporter"". Is this molecule effective to this assay?",train
426,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5586206896551724,"NVS_NR_bER, is one of one assay component(s) measured or calculated from the NVS_NR_bER assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_bER was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_bER, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
427,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7692307692307692,"NVS_NR_bPR, is one of one assay component(s) measured or calculated from the NVS_NR_bPR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_bPR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_bPR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PGR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
428,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6277777777777778,"NVS_NR_cAR, is one of one assay component(s) measured or calculated from the NVS_NR_cAR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_cAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_cAR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
429,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6583333333333333,"NVS_NR_hAR, is one of one assay component(s) measured or calculated from the NVS_NR_hAR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_hAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hAR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
430,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.53,"NVS_NR_hCAR_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hCAR_Antagonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hCAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hCAR_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1I3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
431,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5257575757575758,"NVS_NR_hER, is one of one assay component(s) measured or calculated from the NVS_NR_hER assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_hER was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hER, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
432,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7857142857142857,"NVS_NR_hFXR_Agonist, is one of one assay component(s) measured or calculated from the NVS_NR_hFXR_Agonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hFXR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hFXR_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
433,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7345679012345679,"NVS_NR_hFXR_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hFXR_Antagonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hFXR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hFXR_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
434,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.517361111111111,"NVS_NR_hGR, is one of one assay component(s) measured or calculated from the NVS_NR_hGR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_NR_hGR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hGR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR3C1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
435,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7050691244239631,"NVS_NR_hPPARa, is one of one assay component(s) measured or calculated from the NVS_NR_hPPARa assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hPPARa was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPPARa, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PPARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
436,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6637931034482757,"NVS_NR_hPPARg, is one of one assay component(s) measured or calculated from the NVS_NR_hPPARg assay. It is designed to make measurements of fluorescent polarization, a form of binding reporter, as detected with fluorescence polarization signals by Fluorescence Polarization technology.Data from the assay component NVS_NR_hPPARg was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPPARg, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PPARG. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
437,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6224489795918366,"NVS_NR_hPR, is one of one assay component(s) measured or calculated from the NVS_NR_hPR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_hPR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PGR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
438,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.715909090909091,"NVS_NR_hPXR, is one of one assay component(s) measured or calculated from the NVS_NR_hPXR assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hPXR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPXR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1I2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
439,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_NR_hRAR_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hRAR_Antagonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hRAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hRAR_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene RARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
440,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8823529411764706,"NVS_NR_hRARa_Agonist, is one of one assay component(s) measured or calculated from the NVS_NR_hRARa_Agonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hRARa_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hRARa_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene RARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
441,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7222222222222222,"NVS_NR_hTRa_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hTRa_Antagonist assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with chemiluminescence signals by AlphaLISA immunoassay technology.Data from the assay component NVS_NR_hTRa_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hTRa_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene THRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
442,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5746031746031747,"NVS_NR_mERa, is one of one assay component(s) measured or calculated from the NVS_NR_mERa assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_NR_mERa was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_mERa, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Esr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
443,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7396449704142012,"NVS_NR_rAR, is one of one assay component(s) measured or calculated from the NVS_NR_rAR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_NR_rAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_rAR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Ar. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
444,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5466666666666666,"NVS_OR_gSIGMA_NonSelective, is one of one assay component(s) measured or calculated from the NVS_OR_gSIGMA_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_OR_gSIGMA_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_OR_gSIGMA_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Sigmar1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""misc protein"" intended target family, where the subfamily is ""chaperone"". Is this molecule effective to this assay?",train
445,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3625,"NVS_TR_gDAT, is one of one assay component(s) measured or calculated from the NVS_TR_gDAT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_gDAT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_gDAT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
446,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6590909090909091,"NVS_TR_hAdoT, is one of one assay component(s) measured or calculated from the NVS_TR_hAdoT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hAdoT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hAdoT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC29A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""nucleoside transporter"". Is this molecule effective to this assay?",train
447,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5089285714285714,"NVS_TR_hDAT, is one of one assay component(s) measured or calculated from the NVS_TR_hDAT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hDAT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hDAT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
448,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3788819875776397,"NVS_TR_hNET, is one of one assay component(s) measured or calculated from the NVS_TR_hNET assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hNET was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hNET, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
449,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6909090909090909,"NVS_TR_hSERT, is one of one assay component(s) measured or calculated from the NVS_TR_hSERT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hSERT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hSERT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
450,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5833333333333334,"NVS_TR_rNET, is one of one assay component(s) measured or calculated from the NVS_TR_rNET assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_rNET was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rNET, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
451,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6979166666666667,"NVS_TR_rSERT, is one of one assay component(s) measured or calculated from the NVS_TR_rSERT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_rSERT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rSERT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
452,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6000000000000001,"NVS_TR_rVMAT2, is one of one assay component(s) measured or calculated from the NVS_TR_rVMAT2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_rVMAT2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rVMAT2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc18a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""vesicular transporter"". Is this molecule effective to this assay?",train
453,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5206971677559913,"OT_AR_ARELUC_AG_1440, is one of one assay component(s) measured or calculated from the OT_AR_ARELUC_AG_1440 assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by Luciferase technology.Data from the assay component OT_AR_ARELUC_AG_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARELUC_AG_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
454,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3860544217687075,"OT_AR_ARSRC1_0480, is one of one assay component(s) measured or calculated from the OT_AR_ARSRC1_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_AR_ARSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
455,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4944297082228117,"OT_AR_ARSRC1_0960, is one of one assay component(s) measured or calculated from the OT_AR_ARSRC1_0960 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_AR_ARSRC1_0960 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0960, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
456,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4847926267281106,"OT_ER_ERaERa_0480, is one of one assay component(s) measured or calculated from the OT_ER_ERaERa_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
457,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4645390070921986,"OT_ER_ERaERa_1440, is one of one assay component(s) measured or calculated from the OT_ER_ERaERa_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
458,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5672222222222223,"OT_ER_ERaERb_0480, is one of one assay component(s) measured or calculated from the OT_ER_ERaERb_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
459,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3432835820895522,"OT_ER_ERaERb_1440, is one of one assay component(s) measured or calculated from the OT_ER_ERaERb_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
460,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4533390410958904,"OT_ER_ERbERb_0480, is one of one assay component(s) measured or calculated from the OT_ER_ERbERb_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERbERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
461,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2352941176470588,"OT_ER_ERbERb_1440, is one of one assay component(s) measured or calculated from the OT_ER_ERbERb_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERbERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
462,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4030501089324619,"OT_ERa_GFPERaERE_0120, is one of one assay component(s) measured or calculated from the OT_ERa_GFPERaERE_0120 assay. It is designed to make measurements of fluorescent protein induction, a form of inducible reporter, as detected with optical microscopy: fluorescence microscopy signals by Microscopy technology.Data from the assay component OT_ERa_GFPERaERE_0120 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0120, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
463,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5165562913907285,"OT_ERa_GFPERaERE_0480, is one of one assay component(s) measured or calculated from the OT_ERa_GFPERaERE_0480 assay. It is designed to make measurements of fluorescent protein induction, a form of inducible reporter, as detected with optical microscopy: fluorescence microscopy signals by Microscopy technology.Data from the assay component OT_ERa_GFPERaERE_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
464,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4992727272727272,"OT_FXR_FXRSRC1_0480, is one of one assay component(s) measured or calculated from the OT_FXR_FXRSRC1_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_FXR_FXRSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
465,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.33828125,"OT_FXR_FXRSRC1_1440, is one of one assay component(s) measured or calculated from the OT_FXR_FXRSRC1_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_FXR_FXRSRC1_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
466,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.61121534292266,"OT_NURR1_NURR1RXRa_0480, is one of one assay component(s) measured or calculated from the OT_NURR1_NURR1RXRa_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_NURR1_NURR1RXRa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
467,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8006756756756757,"OT_NURR1_NURR1RXRa_1440, is one of one assay component(s) measured or calculated from the OT_NURR1_NURR1RXRa_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_NURR1_NURR1RXRa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
468,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5796941219826792,"TOX21_ARE_BLA_Agonist_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ARE_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ARE_BLA_Agonist_ch1, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
469,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5204968944099378,"TOX21_ARE_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ARE_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ARE_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
470,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.541349338621548,"TOX21_ARE_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_ARE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_ARE_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.   Is this molecule effective to this assay?",train
471,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4789682539682539,"APR_HepG2_CellCycleArrest_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellCycleArrest_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellCycleArrest_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""proliferation"". Is this molecule effective to this assay?",train
472,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5813008130081301,"APR_HepG2_CellCycleArrest_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellCycleArrest_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellCycleArrest_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""arrest"". Is this molecule effective to this assay?",train
473,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.523358585858586,"APR_HepG2_CellCycleArrest_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellCycleArrest_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellCycleArrest_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""proliferation"". Is this molecule effective to this assay?",train
474,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4742346938775511,"APR_HepG2_CellLoss_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellLoss_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellLoss_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
475,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5222277722277722,"APR_HepG2_CellLoss_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_CellLoss_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_CellLoss_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
476,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6393442622950819,"APR_HepG2_MicrotubuleCSK_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
477,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.42998585572843,"APR_HepG2_MicrotubuleCSK_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
478,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5013550135501355,"APR_HepG2_MicrotubuleCSK_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
479,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.441923076923077,"APR_HepG2_MicrotubuleCSK_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MicrotubuleCSK_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
480,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6253588516746411,"APR_HepG2_MitoMass_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_24hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
481,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7048387096774194,"APR_HepG2_MitoMass_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_24hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
482,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.618172268907563,"APR_HepG2_MitoMass_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_72hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
483,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5121082621082621,"APR_HepG2_MitoMass_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMass_72hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMass_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
484,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.445578231292517,"APR_HepG2_MitoMembPot_1hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_1hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMembPot_1hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMembPot_1h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
485,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6079252577319588,"APR_HepG2_MitoMembPot_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMembPot_24hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMembPot_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
486,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6385964912280702,"APR_HepG2_MitoMembPot_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoMembPot_72hr was analyzed into 2 assay endpoints. This assay endpoint, APR_HepG2_MitoMembPot_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
487,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5982603092783505,"APR_HepG2_MitoticArrest_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoticArrest_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MitoticArrest_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""arrest"". Is this molecule effective to this assay?",train
488,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6222784810126581,"APR_HepG2_MitoticArrest_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_MitoticArrest_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_MitoticArrest_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""arrest"". Is this molecule effective to this assay?",train
489,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5853658536585367,"APR_HepG2_NuclearSize_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_NuclearSize_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_NuclearSize_24h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
490,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.502710027100271,"APR_HepG2_NuclearSize_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_NuclearSize_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_NuclearSize_72h_dn, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
491,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5590551181102362,"APR_HepG2_NuclearSize_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_NuclearSize_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_NuclearSize_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""organelle conformation"". Is this molecule effective to this assay?",train
492,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4468085106382978,"APR_HepG2_StressKinase_1hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_1hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_StressKinase_1hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_StressKinase_1h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""stress response"". Is this molecule effective to this assay?",train
493,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5385208012326657,"APR_HepG2_StressKinase_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_StressKinase_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_StressKinase_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""stress response"". Is this molecule effective to this assay?",train
494,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.623444976076555,"APR_HepG2_StressKinase_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_StressKinase_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_StressKinase_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""stress response"". Is this molecule effective to this assay?",train
495,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.621994342291372,"APR_HepG2_p53Act_24hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_p53Act_24hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_p53Act_24h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""dna binding"" intended target family, where the subfamily is ""tumor suppressor"". Is this molecule effective to this assay?",train
496,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6240121580547111,"APR_HepG2_p53Act_72hr, is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.Data from the assay component APR_HepG2_p53Act_72hr was analyzed into 2 assay endpoints. 
This assay endpoint, APR_HepG2_p53Act_72h_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""dna binding"" intended target family, where the subfamily is ""tumor suppressor"". Is this molecule effective to this assay?",train
497,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7127016129032258,"ATG_AP_1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_AP_1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
498,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4685482115649713,"ATG_AP_1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_AP_1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_AP_1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOS and JUN. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
499,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5411457361448031,"ATG_AP_2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_AP_2_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
500,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5964566929133859,"ATG_AP_2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_AP_2_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_AP_2_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TFAP2A and TFAP2B and TFAP2D. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-turn-helix leucine zipper. Is this molecule effective to this assay?",train
501,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6594488188976377,"ATG_AR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_AR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
502,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5266932270916335,"ATG_AR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_AR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_AR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
503,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4752155172413792,"ATG_Ahr_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Ahr_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
504,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6439805825242718,"ATG_Ahr_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Ahr_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Ahr_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AHR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein. Is this molecule effective to this assay?",train
505,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6239316239316238,"ATG_BRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_BRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
506,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5202327426606719,"ATG_BRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_BRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_BRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SMAD1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is Smad protein. Is this molecule effective to this assay?",train
507,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.689142133586578,"ATG_CAR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_CAR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
508,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5059760956175299,"ATG_CAR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_CAR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_CAR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
509,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6847677595628414,"ATG_CMV_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_CMV_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
510,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5033163265306122,"ATG_CMV_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_CMV_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_CMV_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
511,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3675889328063241,"ATG_CRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_CRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
512,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4831304024537596,"ATG_CRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_CRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_CRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CREB3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
513,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5166666666666666,"ATG_C_EBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_C_EBP_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
514,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4801551389786684,"ATG_C_EBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_C_EBP_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_C_EBP_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CEBPB. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
515,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5671887291711364,"ATG_DR4_LXR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_DR4_LXR_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
516,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3561507936507936,"ATG_DR4_LXR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_DR4_LXR_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_DR4_LXR_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2 and NR1H3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
517,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5670731707317073,"ATG_DR5_RAR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_DR5_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
518,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5058823529411764,"ATG_DR5_RAR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_DR5_RAR_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_DR5_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA and RARB and RARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
519,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6457916944259383,"ATG_E2F_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_E2F_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
520,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5436507936507936,"ATG_E2F_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_E2F_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_E2F_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene E2F1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is E2F transcription factor. Is this molecule effective to this assay?",train
521,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5793001841620626,"ATG_EGR_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_EGR_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_EGR_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene EGR1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
522,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7651155428933207,"ATG_ERE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ERE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
523,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4353109903381643,"ATG_ERE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_ERE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_ERE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
524,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4374501992031873,"ATG_ERRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ERRa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
525,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4429133858267716,"ATG_ERRg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ERRg_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
526,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5254901960784314,"ATG_ERRg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_ERRg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_ERRg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESRRG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
527,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4417005879692446,"ATG_ERa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_ERa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_ERa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
528,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6082554517133957,"ATG_E_Box_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_E_Box_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
529,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6182926829268293,"ATG_E_Box_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_E_Box_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_E_Box_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene USF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein. Is this molecule effective to this assay?",train
530,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4998327759197324,"ATG_Ets_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Ets_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
531,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9137254901960784,"ATG_Ets_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Ets_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Ets_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ETS1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is winged helix-turn-helix. Is this molecule effective to this assay?",train
532,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5617529880478087,"ATG_FXR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_FXR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_FXR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
533,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5253333333333334,"ATG_FoxA2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_FoxA2_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
534,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5901639344262295,"ATG_FoxA2_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_FoxA2_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_FoxA2_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXA2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein. Is this molecule effective to this assay?",train
535,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5711951447245565,"ATG_FoxO_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_FoxO_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
536,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2980392156862745,"ATG_FoxO_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_FoxO_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_FoxO_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXO1 and FOXO3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein. Is this molecule effective to this assay?",train
537,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5824120603015075,"ATG_GAL4_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GAL4_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
538,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4419294990723562,"ATG_GATA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GATA_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
539,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5885826771653544,"ATG_GATA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GATA_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GATA_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GATA1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is GATA proteins. Is this molecule effective to this assay?",train
540,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5810276679841897,"ATG_GLI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GLI_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
541,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4296814296814297,"ATG_GLI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GLI_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GLI_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GLI1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
542,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4526041666666667,"ATG_GRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
543,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5605278255880666,"ATG_GRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
544,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4265873015873015,"ATG_GR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_GR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
545,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7913306451612904,"ATG_GR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_GR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_GR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
546,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.571498892444007,"ATG_HIF1a_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HIF1a_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
547,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5718679330619629,"ATG_HIF1a_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HIF1a_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HIF1a_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HIF1A. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein. Is this molecule effective to this assay?",train
548,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7657370517928286,"ATG_HNF4a_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HNF4a_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
549,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5396825396825397,"ATG_HNF4a_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HNF4a_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HNF4a_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HNF4A. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
550,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6970766129032258,"ATG_HNF6_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HNF6_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
551,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2635046113306982,"ATG_HNF6_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HNF6_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HNF6_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ONECUT1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is homeobox protein. Is this molecule effective to this assay?",train
552,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6910569105691057,"ATG_HSE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_HSE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
553,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5148809523809523,"ATG_HSE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_HSE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_HSE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HSF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein. Is this molecule effective to this assay?",train
554,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5589646464646465,"ATG_IR1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_IR1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
555,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5736549165120594,"ATG_IR1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_IR1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_IR1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
556,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5641156462585033,"ATG_ISRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_ISRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
557,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7938508064516129,"ATG_LXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_LXRa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
558,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4842896174863388,"ATG_LXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_LXRa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_LXRa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
559,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5215686274509803,"ATG_LXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_LXRb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
560,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3948087431693989,"ATG_LXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_LXRb_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_LXRb_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
561,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4829128074097732,"ATG_MRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_MRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_MRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MTF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
562,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6862745098039216,"ATG_M_06_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_06_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_06_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
563,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4381466486729645,"ATG_M_19_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_19_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
564,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.640625,"ATG_M_19_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_19_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
565,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4352941176470588,"ATG_M_19_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_19_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_19_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
566,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5783926218708828,"ATG_M_32_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_32_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
567,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4127490039840638,"ATG_M_32_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_32_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_32_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
568,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2868525896414343,"ATG_M_32_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_M_32_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
569,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8759920634920635,"ATG_M_32_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_32_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_32_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
570,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7333333333333334,"ATG_M_61_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_M_61_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_M_61_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
571,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5881147540983607,"ATG_Myb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Myb_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
572,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6358565737051793,"ATG_Myb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Myb_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Myb_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYB. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is MYB proteins. Is this molecule effective to this assay?",train
573,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8998015873015873,"ATG_Myc_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Myc_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
574,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4717553688141923,"ATG_Myc_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Myc_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Myc_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYC. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper. Is this molecule effective to this assay?",train
575,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7493333333333334,"ATG_NFI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NFI_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
576,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4755859374999999,"ATG_NFI_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NFI_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NFI_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFIA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear factor I. Is this molecule effective to this assay?",train
577,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6267509215376513,"ATG_NF_kB_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NF_kB_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
578,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4384298828743273,"ATG_NF_kB_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NF_kB_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NF_kB_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFKB1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B. Is this molecule effective to this assay?",train
579,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.653106922933383,"ATG_NRF1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NRF1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
580,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4453441295546558,"ATG_NRF1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NRF1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NRF1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NRF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear respiratory factors. Is this molecule effective to this assay?",train
581,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8129117259552042,"ATG_NRF2_ARE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NRF2_ARE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
582,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4830556075641265,"ATG_NRF2_ARE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NRF2_ARE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NRF2_ARE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFE2L2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
583,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5085638998682477,"ATG_NURR1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_NURR1_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
584,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6314083080040527,"ATG_NURR1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_NURR1_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_NURR1_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR4A2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
585,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2244094488188976,"ATG_Oct_MLP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Oct_MLP_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
586,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4939418123775665,"ATG_Oct_MLP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Oct_MLP_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Oct_MLP_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene POU2F1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is POU domain protein. Is this molecule effective to this assay?",train
587,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6428571428571429,"ATG_PBREM_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PBREM_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
588,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.536682615629984,"ATG_PBREM_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PBREM_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PBREM_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
589,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.740079365079365,"ATG_PPARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PPARa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
590,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5706180344478218,"ATG_PPARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPARa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPARa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
591,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4756972111553785,"ATG_PPARd_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPARd_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPARd_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARD. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
592,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5792298570804468,"ATG_PPARg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPARg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPARg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
593,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7350649350649351,"ATG_PPRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PPRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
594,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5662249089359064,"ATG_PPRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PPRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PPRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA and PPARD and PPARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
595,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.555921052631579,"ATG_PXRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PXRE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
596,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4895441651823999,"ATG_PXRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PXRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_PXRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
597,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7125984251968505,"ATG_PXR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_PXR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
598,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.569302615193026,"ATG_PXR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_PXR_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_PXR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
599,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5937172774869109,"ATG_Pax6_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Pax6_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Pax6_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PAX6. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is paired box protein. Is this molecule effective to this assay?",train
600,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6051521208083499,"ATG_RARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RARa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
601,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5761752399704652,"ATG_RARa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RARa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RARa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
602,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6166666666666667,"ATG_RARb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RARb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
603,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5609561752988048,"ATG_RARb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RARb_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RARb_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARB. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
604,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5846666666666667,"ATG_RARg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RARg_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
605,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5820962663067926,"ATG_RARg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RARg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RARg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARG. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
606,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7529411764705882,"ATG_RORE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RORE_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
607,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5634352635003252,"ATG_RORE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RORE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RORE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORA and RORB and RORC. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
608,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6964143426294821,"ATG_RORb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RORb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
609,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5968379446640316,"ATG_RORg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RORg_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
610,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.615686274509804,"ATG_RORg_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RORg_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RORg_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORC. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan. Is this molecule effective to this assay?",train
611,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3464566929133858,"ATG_RXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RXRa_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
612,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7212301587301587,"ATG_RXRa_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RXRa_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_RXRa_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
613,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.56,"ATG_RXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_RXRb_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
614,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5131268436578171,"ATG_RXRb_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_RXRb_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_RXRb_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
615,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4677206851119895,"ATG_SREBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_SREBP_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
616,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5730305578917858,"ATG_SREBP_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_SREBP_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_SREBP_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SREBF1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper. Is this molecule effective to this assay?",train
617,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.484230055658627,"ATG_STAT3_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_STAT3_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
618,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2374501992031872,"ATG_STAT3_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_STAT3_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_STAT3_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene STAT3. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein. Is this molecule effective to this assay?",train
619,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5823451910408433,"ATG_Sox_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Sox_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
620,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4807830459770115,"ATG_Sox_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Sox_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Sox_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SOX1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein. Is this molecule effective to this assay?",train
621,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3491436100131752,"ATG_Sp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Sp1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
622,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4967296063186474,"ATG_Sp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Sp1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Sp1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SP1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger. Is this molecule effective to this assay?",train
623,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5390243902439024,"ATG_TAL_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TAL_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
624,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6403688524590163,"ATG_TAL_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TAL_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TAL_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
625,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6240157480314961,"ATG_TA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TA_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
626,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6363636363636364,"ATG_TA_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TA_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TA_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . _x000D_
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker. Is this molecule effective to this assay?",train
627,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.614828528607952,"ATG_TCF_b_cat_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TCF_b_cat_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
628,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4488188976377953,"ATG_TCF_b_cat_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TCF_b_cat_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TCF_b_cat_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TCF7 and TCF7L2 and LEF1 and TCF7L1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein. Is this molecule effective to this assay?",train
629,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.51731893837157,"ATG_TGFb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_TGFb_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
630,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5596757852077001,"ATG_TGFb_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_TGFb_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_TGFb_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TGFB1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta. Is this molecule effective to this assay?",train
631,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6844621513944223,"ATG_THRa1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_THRa1_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
632,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4588541666666667,"ATG_THRa1_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_THRa1_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_THRa1_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene THRA. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
633,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.574250138011409,"ATG_VDRE_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_VDRE_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_VDRE_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
634,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7047244094488188,"ATG_VDR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_VDR_TRANS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
635,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7473333333333334,"ATG_VDR_TRANS, is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_VDR_TRANS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_VDR_TRANS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
636,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5259259259259259,"ATG_XTT_Cytotoxicity, is one of one assay component(s) measured or calculated from the ATG_XTT_Cytotoxicity assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by XTT cytotoxicity assay technology.Data from the assay component ATG_XTT_Cytotoxicity was analyzed into 1 assay endpoint. This assay endpoint, ATG_XTT_Cytotoxicity_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
637,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5098425196850394,"ATG_Xbp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_Xbp1_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
638,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.520414673046252,"ATG_Xbp1_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_Xbp1_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_Xbp1_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene XBP1. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
639,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5827770360480641,"ATG_p53_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.ATG_p53_CIS_dn was not developed or optimized to detect loss of signal. Use data with caution. Is this molecule effective to this assay?",train
640,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4279977051061389,"ATG_p53_CIS, is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.Data from the assay component ATG_p53_CIS was analyzed into 1 assay endpoint. _x000D_
This assay endpoint, ATG_p53_CIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. _x000D_
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TP53. _x000D_
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. _x000D_
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor. Is this molecule effective to this assay?",train
641,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.481651376146789,"BSK_3C_Eselectin is an assay component measured in the BSK_3C assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Eselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
642,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.485930735930736,"BSK_3C_HLADR is an assay component measured in the BSK_3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_HLADR was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_HLADR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""MHC Class II"". Is this molecule effective to this assay?",train
643,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5482993197278911,"BSK_3C_ICAM1 is an assay component measured in the BSK_3C assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_ICAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_ICAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
644,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4734402852049911,"BSK_3C_IL8 is an assay component measured in the BSK_3C assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
645,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4568627450980392,"BSK_3C_MCP1 is an assay component measured in the BSK_3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
646,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5530679933665008,"BSK_3C_MIG is an assay component measured in the BSK_3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
647,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5338589981447124,"BSK_3C_Proliferation is an assay component measured in the BSK_3C assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.Data from the assay component BSK_3C_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_3C_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
648,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4702719797596457,"BSK_3C_SRB is an assay component measured in the BSK_3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_3C_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_3C_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
649,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4831223628691983,"BSK_3C_Thrombomodulin is an assay component measured in the BSK_3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Thrombomodulin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
650,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5054744525547445,"BSK_3C_Thrombomodulin is an assay component measured in the BSK_3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Thrombomodulin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
651,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4838167297183691,"BSK_3C_TissueFactor is an assay component measured in the BSK_3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_TissueFactor_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
652,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6864035087719298,"BSK_3C_TissueFactor is an assay component measured in the BSK_3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_TissueFactor_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
653,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4875950380152061,"BSK_3C_VCAM1 is an assay component measured in the BSK_3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
654,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5296740994854202,"BSK_3C_Vis is an assay component measured in the BSK_3C assay. It measures NA related to cell morphology using light microscopy technology.Data from the assay component BSK_3C_Vis was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_Vis_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, loss-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell morphology"" intended target family, where the subfamily is ""cell conformation"". Is this molecule effective to this assay?",train
655,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4948717948717949,"BSK_3C_uPAR is an assay component measured in the BSK_3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_3C_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
656,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4960119641076769,"BSK_4H_Eotaxin3 is an assay component measured in the BSK_4H assay. It measures Eotaxin-3 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_Eotaxin3 was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_Eotaxin3_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL26. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
657,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4731292517006802,"BSK_4H_MCP1 is an assay component measured in the BSK_4H assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
658,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4903061224489796,"BSK_4H_Pselectin is an assay component measured in the BSK_4H assay. It measures P-Selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_Pselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_Pselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELP. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
659,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7040816326530612,"BSK_4H_Pselectin is an assay component measured in the BSK_4H assay. It measures P-Selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_Pselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_Pselectin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELP. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
660,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.468362905925678,"BSK_4H_SRB is an assay component measured in the BSK_4H assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_4H_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_4H_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
661,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.513893653516295,"BSK_4H_VCAM1 is an assay component measured in the BSK_4H assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
662,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4938235294117646,"BSK_4H_VEGFRII is an assay component measured in the BSK_4H assay. It measures VEGFRII antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_VEGFRII was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_VEGFRII_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
663,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5215686274509803,"BSK_4H_uPAR is an assay component measured in the BSK_4H assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
664,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6163522012578616,"BSK_4H_uPAR is an assay component measured in the BSK_4H assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_4H_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_4H_uPAR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
665,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5427392739273927,"BSK_BE3C_HLADR is an assay component measured in the BSK_BE3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_HLADR was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_HLADR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""MHC Class II"". Is this molecule effective to this assay?",train
666,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5798981009726725,"BSK_BE3C_IL1a is an assay component measured in the BSK_BE3C assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_IL1a_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
667,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5284050811573747,"BSK_BE3C_IP10 is an assay component measured in the BSK_BE3C assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_IP10_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
668,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6205692803437165,"BSK_BE3C_MIG is an assay component measured in the BSK_BE3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
669,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5591176470588235,"BSK_BE3C_MMP1 is an assay component measured in the BSK_BE3C assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_MMP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
670,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5678104575163399,"BSK_BE3C_MMP1 is an assay component measured in the BSK_BE3C assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_MMP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
671,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4970501474926253,"BSK_BE3C_PAI1 is an assay component measured in the BSK_BE3C assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_PAI1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_PAI1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator inhibitor"". Is this molecule effective to this assay?",train
672,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4952380952380952,"BSK_BE3C_SRB is an assay component measured in the BSK_BE3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_BE3C_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_BE3C_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
673,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5867248062015504,"BSK_BE3C_TGFb1 is an assay component measured in the BSK_BE3C assay. It measures TGF-b1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_TGFb1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_TGFb1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""growth factor"" intended target family, where the subfamily is ""transforming growth factor beta"". Is this molecule effective to this assay?",train
674,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5397727272727273,"BSK_BE3C_tPA is an assay component measured in the BSK_BE3C assay. It measures tPA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_tPA was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_tPA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAT. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
675,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5697674418604651,"BSK_BE3C_uPAR is an assay component measured in the BSK_BE3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
676,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1898734177215189,"BSK_BE3C_uPAR is an assay component measured in the BSK_BE3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_uPAR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
677,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5564049586776859,"BSK_BE3C_uPA is an assay component measured in the BSK_BE3C assay. It measures uPA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_BE3C_uPA was analyzed into 2 assay endpoints. This assay endpoint, BSK_BE3C_uPA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
678,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5539152759948651,"BSK_CASM3C_HLADR is an assay component measured in the BSK_CASM3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_HLADR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_HLADR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""MHC Class II"". Is this molecule effective to this assay?",train
679,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5502148227712138,"BSK_CASM3C_IL6 is an assay component measured in the BSK_CASM3C assay. It measures IL-6 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_IL6 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_IL6_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
680,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6307977736549165,"BSK_CASM3C_IL6 is an assay component measured in the BSK_CASM3C assay. It measures IL-6 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_IL6 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_IL6_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
681,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4799836601307189,"BSK_CASM3C_IL8 is an assay component measured in the BSK_CASM3C assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
682,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5059861373660995,"BSK_CASM3C_LDLR is an assay component measured in the BSK_CASM3C assay. It measures LDLR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_LDLR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_LDLR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene LDLR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""misc protein"" intended target family, where the subfamily is ""LDL receptor"". Is this molecule effective to this assay?",train
683,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6890184645286687,"BSK_CASM3C_LDLR is an assay component measured in the BSK_CASM3C assay. It measures LDLR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_LDLR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_LDLR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene LDLR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""misc protein"" intended target family, where the subfamily is ""LDL receptor"". Is this molecule effective to this assay?",train
684,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4992555831265508,"BSK_CASM3C_MCP1 is an assay component measured in the BSK_CASM3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
685,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7515923566878981,"BSK_CASM3C_MCP1 is an assay component measured in the BSK_CASM3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
686,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4914772727272727,"BSK_CASM3C_MCSF is an assay component measured in the BSK_CASM3C assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCSF_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
687,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7898089171974522,"BSK_CASM3C_MCSF is an assay component measured in the BSK_CASM3C assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MCSF_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
688,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5641025641025641,"BSK_CASM3C_MIG is an assay component measured in the BSK_CASM3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
689,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.521283255086072,"BSK_CASM3C_Proliferation is an assay component measured in the BSK_CASM3C assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.Data from the assay component BSK_CASM3C_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_CASM3C_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
690,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4955882352941176,"BSK_CASM3C_SAA is an assay component measured in the BSK_CASM3C assay. It measures SAA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_SAA was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_SAA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""apolipoproteins"". Is this molecule effective to this assay?",train
691,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9375,"BSK_CASM3C_SAA is an assay component measured in the BSK_CASM3C assay. It measures SAA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_SAA was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_SAA_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""apolipoproteins"". Is this molecule effective to this assay?",train
692,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5406976744186046,"BSK_CASM3C_SRB is an assay component measured in the BSK_CASM3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_CASM3C_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_CASM3C_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
693,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5418181818181818,"BSK_CASM3C_Thrombomodulin is an assay component measured in the BSK_CASM3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_Thrombomodulin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
694,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4558638083228247,"BSK_CASM3C_Thrombomodulin is an assay component measured in the BSK_CASM3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_Thrombomodulin was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_Thrombomodulin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
695,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5304136253041363,"BSK_CASM3C_TissueFactor is an assay component measured in the BSK_CASM3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_TissueFactor_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
696,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5076923076923077,"BSK_CASM3C_VCAM1 is an assay component measured in the BSK_CASM3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
697,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4387755102040816,"BSK_CASM3C_VCAM1 is an assay component measured in the BSK_CASM3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_VCAM1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
698,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.555871212121212,"BSK_CASM3C_uPAR is an assay component measured in the BSK_CASM3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_uPAR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
699,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4,"BSK_CASM3C_uPAR is an assay component measured in the BSK_CASM3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_CASM3C_uPAR was analyzed into 2 assay endpoints. This assay endpoint, BSK_CASM3C_uPAR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator"". Is this molecule effective to this assay?",train
700,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6481481481481483,"BSK_KF3CT_ICAM1 is an assay component measured in the BSK_KF3CT assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_ICAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_ICAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
701,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6267573696145124,"BSK_KF3CT_IL1a is an assay component measured in the BSK_KF3CT assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_IL1a_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
702,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5418066442702502,"BSK_KF3CT_IP10 is an assay component measured in the BSK_KF3CT assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_IP10_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
703,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5153846153846153,"BSK_KF3CT_IP10 is an assay component measured in the BSK_KF3CT assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_IP10_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
704,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5499999999999999,"BSK_KF3CT_MCP1 is an assay component measured in the BSK_KF3CT assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
705,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3923076923076923,"BSK_KF3CT_MCP1 is an assay component measured in the BSK_KF3CT assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_MCP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
706,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5256684491978609,"BSK_KF3CT_MMP9 is an assay component measured in the BSK_KF3CT assay. It measures MMP-9 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_MMP9 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_MMP9_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
707,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6499477533960293,"BSK_KF3CT_SRB is an assay component measured in the BSK_KF3CT assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_KF3CT_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_KF3CT_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
708,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6324444444444445,"BSK_KF3CT_TGFb1 is an assay component measured in the BSK_KF3CT assay. It measures TGF-b1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_TGFb1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_TGFb1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""growth factor"" intended target family, where the subfamily is ""transforming growth factor beta"". Is this molecule effective to this assay?",train
709,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6610586011342154,"BSK_KF3CT_TIMP2 is an assay component measured in the BSK_KF3CT assay. It measures TIMP-2 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_TIMP2 was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_TIMP2_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease inhibitor"" intended target family, where the subfamily is ""metalloproteinase inhibitor"". Is this molecule effective to this assay?",train
710,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6843672456575683,"BSK_KF3CT_uPA is an assay component measured in the BSK_KF3CT assay. It measures uPA antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_KF3CT_uPA was analyzed into 2 assay endpoints. This assay endpoint, BSK_KF3CT_uPA_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
711,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5189152996317375,"BSK_LPS_CD40 is an assay component measured in the BSK_LPS assay. It measures CD40 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_CD40 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_CD40_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
712,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4584304584304584,"BSK_LPS_Eselectin is an assay component measured in the BSK_LPS assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_Eselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
713,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7426160337552742,"BSK_LPS_Eselectin is an assay component measured in the BSK_LPS assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_Eselectin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
714,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5842336934773911,"BSK_LPS_IL1a is an assay component measured in the BSK_LPS assay. It measures IL-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL1a_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
715,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3694267515923567,"BSK_LPS_IL1a is an assay component measured in the BSK_LPS assay. It measures IL-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL1a was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL1a_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
716,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4605363984674329,"BSK_LPS_IL8 is an assay component measured in the BSK_LPS assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
717,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5311827956989248,"BSK_LPS_IL8 is an assay component measured in the BSK_LPS assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_IL8_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
718,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4823008849557522,"BSK_LPS_MCP1 is an assay component measured in the BSK_LPS assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
719,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5112914608327452,"BSK_LPS_MCSF is an assay component measured in the BSK_LPS assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_MCSF_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
720,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5330484330484331,"BSK_LPS_PGE2 is an assay component measured in the BSK_LPS assay. It measures PGE2 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_PGE2 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_PGE2_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PTGER2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
721,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.35,"BSK_LPS_PGE2 is an assay component measured in the BSK_LPS assay. It measures PGE2 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_PGE2 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_PGE2_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene PTGER2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
722,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4917977904251758,"BSK_LPS_SRB is an assay component measured in the BSK_LPS assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_LPS_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_LPS_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
723,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5722992854140394,"BSK_LPS_TNFa is an assay component measured in the BSK_LPS assay. It measures TNF-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TNFa was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TNFa_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TNF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
724,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3300415800415801,"BSK_LPS_TNFa is an assay component measured in the BSK_LPS assay. It measures TNF-a antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TNFa was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TNFa_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene TNF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
725,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.561323155216285,"BSK_LPS_TissueFactor is an assay component measured in the BSK_LPS assay. It measures CD142 Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TissueFactor_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
726,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6927152317880795,"BSK_LPS_TissueFactor is an assay component measured in the BSK_LPS assay. It measures CD142 Tissue Factor antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_TissueFactor was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_TissueFactor_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""coagulation factor"". Is this molecule effective to this assay?",train
727,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4799238490827276,"BSK_LPS_VCAM1 is an assay component measured in the BSK_LPS assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_LPS_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_LPS_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
728,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4676236044657097,"BSK_SAg_CD38, is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.Data from the assay component BSK_SAg_CD38 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_CD38_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD38. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""other cytokine"". Is this molecule effective to this assay?",train
729,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5017628205128205,"BSK_SAg_CD40, is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.Data from the assay component BSK_SAg_CD40 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_CD40_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
730,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4882409793814433,"BSK_SAg_CD69, is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.Data from the assay component BSK_SAg_CD69 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_CD69_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD69. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""inflammatory factor"". Is this molecule effective to this assay?",train
731,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4433962264150943,"BSK_SAg_Eselectin is an assay component measured in the BSK_SAg assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_Eselectin_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
732,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6920529801324503,"BSK_SAg_Eselectin is an assay component measured in the BSK_SAg assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_Eselectin was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_Eselectin_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""selectins"". Is this molecule effective to this assay?",train
733,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.45317055393586,"BSK_SAg_IL8 is an assay component measured in the BSK_SAg assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
734,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7463576158940397,"BSK_SAg_IL8 is an assay component measured in the BSK_SAg assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_IL8_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
735,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4515117994100295,"BSK_SAg_MCP1 is an assay component measured in the BSK_SAg assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_MCP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_MCP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
736,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4229024943310657,"BSK_SAg_MIG is an assay component measured in the BSK_SAg assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_SAg_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
737,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4800453514739229,"BSK_SAg_PBMCCytotoxicity is an assay component measured in the BSK_SAg assay. It measures Alamar blue related to cell death using Alamar Blue Reduction technology.Data from the assay component BSK_SAg_PBMCCytotoxicity was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_PBMCCytotoxicity_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""proliferation"". Is this molecule effective to this assay?",train
738,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3955296404275996,"BSK_SAg_PBMCCytotoxicity is an assay component measured in the BSK_SAg assay. It measures Alamar blue related to cell death using Alamar Blue Reduction technology.Data from the assay component BSK_SAg_PBMCCytotoxicity was analyzed into 2 assay endpoints. This assay endpoint, BSK_SAg_PBMCCytotoxicity_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
739,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5251543209876544,"BSK_SAg_Proliferation is an assay component in the BSK_SAg assay. It measures protein content, a form of viability reporter, as detected with absorbance signals by Sulforhodamine staining technology. Data from the assay component BSK_SAg_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_SAg_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
740,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.505229419703104,"BSK_SAg_SRB is an assay component measured in the BSK_SAg assay. It measures protein content, a form of viability reporter, as detected with absorbance signals by Sulforhodamine staining technology.Data from the assay component BSK_SAg_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_SAg_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
741,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4362334032145352,"BSK_hDFCGF_CollagenIII is an assay component measured in the BSK_hDFCGF assay. It measures Collagen antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_CollagenIII was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_CollagenIII_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene COL3A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""collagen"". Is this molecule effective to this assay?",train
742,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4782608695652174,"BSK_hDFCGF_EGFR is an assay component measured in the BSK_hDFCGF assay. It measures EGFR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_EGFR was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_EGFR_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
743,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.556989247311828,"BSK_hDFCGF_EGFR is an assay component measured in the BSK_hDFCGF assay. It measures EGFR antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_EGFR was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_EGFR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
744,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5174129353233831,"BSK_hDFCGF_IL8 is an assay component measured in the BSK_hDFCGF assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_IL8 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_IL8_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""interleukins"". Is this molecule effective to this assay?",train
745,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5381461675579322,"BSK_hDFCGF_IP10 is an assay component measured in the BSK_hDFCGF assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_IP10 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_IP10_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
746,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5133264105226722,"BSK_hDFCGF_MCSF is an assay component measured in the BSK_hDFCGF assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MCSF was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MCSF_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""colony stimulating factor"". Is this molecule effective to this assay?",train
747,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5742404792468978,"BSK_hDFCGF_MIG is an assay component measured in the BSK_hDFCGF assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MIG was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MIG_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""chemotactic factor"". Is this molecule effective to this assay?",train
748,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5067255149222363,"BSK_hDFCGF_MMP1 is an assay component measured in the BSK_hDFCGF assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MMP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
749,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3304635761589404,"BSK_hDFCGF_MMP1 is an assay component measured in the BSK_hDFCGF assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_MMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_MMP1_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
750,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5049319727891157,"BSK_hDFCGF_PAI1 is an assay component measured in the BSK_hDFCGF assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_PAI1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_PAI1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cytokine"" intended target family, where the subfamily is ""plasmogen activator inhibitor"". Is this molecule effective to this assay?",train
751,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4737411183194316,"BSK_hDFCGF_Proliferation is an assay component measured in the BSK_hDFCGF assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.Data from the assay component BSK_hDFCGF_Proliferation was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_hDFCGF_Proliferation_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
752,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4787234042553191,"BSK_hDFCGF_SRB is an assay component measured in the BSK_hDFCGF assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.Data from the assay component BSK_hDFCGF_SRB was analyzed into 2 assay endpoints. 
This assay endpoint, BSK_hDFCGF_SRB_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell cycle"" intended target family, where the subfamily is ""cytotoxicity"". Is this molecule effective to this assay?",train
753,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5726799242424242,"BSK_hDFCGF_TIMP1 is an assay component measured in the BSK_hDFCGF assay. It measures TIMP-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_TIMP1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_TIMP1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease inhibitor"" intended target family, where the subfamily is ""metalloproteinase inhibitor"". Is this molecule effective to this assay?",train
754,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.493885394828791,"BSK_hDFCGF_VCAM1 is an assay component measured in the BSK_hDFCGF assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.Data from the assay component BSK_hDFCGF_VCAM1 was analyzed into 2 assay endpoints. This assay endpoint, BSK_hDFCGF_VCAM1_down, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cell adhesion molecules"" intended target family, where the subfamily is ""Immunoglobulin CAM"". Is this molecule effective to this assay?",train
755,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.59375,"CEETOX_H295R_11DCORT, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_11DCORT was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_11DCORT_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 11-Deoxycortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
756,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5160984848484849,"CEETOX_H295R_ANDR, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ANDR was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ANDR_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Androstenedione in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens. Is this molecule effective to this assay?",train
757,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4576744186046512,"CEETOX_H295R_CORTISOL, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_CORTISOL was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_CORTISOL_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Cortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
758,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6046511627906976,"CEETOX_H295R_DOC, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_DOC was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_DOC_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
759,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5641646489104116,"CEETOX_H295R_DOC, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_DOC was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_DOC_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids. Is this molecule effective to this assay?",train
760,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3916666666666666,"CEETOX_H295R_ESTRADIOL, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRADIOL was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRADIOL_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
761,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4894613583138173,"CEETOX_H295R_ESTRADIOL, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRADIOL was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRADIOL_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
762,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4030131826741996,"CEETOX_H295R_ESTRONE, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRONE was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRONE_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estrone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
763,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1904761904761904,"CEETOX_H295R_ESTRONE, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_ESTRONE was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_ESTRONE_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estrone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens. Is this molecule effective to this assay?",train
764,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4023323615160349,"CEETOX_H295R_OHPREG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_OHPREG_up was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_OHPREG_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxypregnenolone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
765,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5038461538461538,"CEETOX_H295R_OHPROG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_OHPROG was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_OHPROG_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
766,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6042884990253412,"CEETOX_H295R_OHPROG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_OHPROG_up was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_OHPROG_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
767,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6270903010033444,"CEETOX_H295R_PROG, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_PROG was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_PROG_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Progesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens. Is this molecule effective to this assay?",train
768,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4173913043478261,"CEETOX_H295R_TESTO, is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.Data from the assay component CEETOX_H295R_TESTO was analyzed into 2 assay endpoints. This assay endpoint, CEETOX_H295R_TESTO_dn, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Testosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens. Is this molecule effective to this assay?",train
769,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5611111111111111,"CLD_ABCB1_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_ABCB1_48hr was analyzed at the endpoint, CLD_ABCB1_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter. Is this molecule effective to this assay?",train
770,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3166666666666666,"CLD_ABCG2_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_ABCG2_48hr was analyzed at the endpoint, CLD_ABCG2_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCG2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter. Is this molecule effective to this assay?",train
771,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6733212341197822,"CLD_CYP1A1_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A1_24hr was analyzed at the endpoint, CLD_CYP1A1_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
772,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6569872958257712,"CLD_CYP1A1_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A1_48hr was analyzed at the endpoint, CLD_CYP1A1_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
773,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6591836734693878,"CLD_CYP1A1_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A1_6hr was analyzed at the endpoint, CLD_CYP1A1_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
774,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4797979797979798,"CLD_CYP1A2_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A2_24hr was analyzed at the endpoint, CLD_CYP1A2_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
775,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5555555555555555,"CLD_CYP1A2_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A2_48hr was analyzed at the endpoint, CLD_CYP1A2_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
776,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6688034188034188,"CLD_CYP1A2_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP1A2_6hr was analyzed at the endpoint, CLD_CYP1A2_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
777,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6921768707482994,"CLD_CYP2B6_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP2B6_24hr was analyzed at the endpoint, CLD_CYP2B6_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
778,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7006688963210702,"CLD_CYP2B6_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP2B6_48hr was analyzed at the endpoint, CLD_CYP2B6_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
779,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6842105263157895,"CLD_CYP2B6_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP2B6_6hr was analyzed at the endpoint, CLD_CYP2B6_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
780,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5888888888888889,"CLD_CYP3A4_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP3A4_24hr was analyzed at the endpoint, CLD_CYP3A4_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
781,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6890909090909091,"CLD_CYP3A4_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP3A4_48hr was analyzed at the endpoint, CLD_CYP3A4_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
782,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6609686609686609,"CLD_CYP3A4_6hr, is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_CYP3A4_6hr was analyzed at the endpoint, CLD_CYP3A4_6hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism. Is this molecule effective to this assay?",train
783,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5681818181818181,"CLD_GSTA2_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_GSTA2_48hr was analyzed at the endpoint, CLD_GSTA2_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GSTA2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is alkyl and aryl transferase. Is this molecule effective to this assay?",train
784,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5,"CLD_SULT2A_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_SULT2A_24hr was analyzed at the endpoint, CLD_SULT2A_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase. Is this molecule effective to this assay?",train
785,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5247747747747747,"CLD_SULT2A_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_SULT2A_48hr was analyzed at the endpoint, CLD_SULT2A_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase. Is this molecule effective to this assay?",train
786,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.521341463414634,"CLD_UGT1A1_24hr, is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_UGT1A1_24hr was analyzed at the endpoint, CLD_UGT1A1_24hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase. Is this molecule effective to this assay?",train
787,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6705426356589148,"CLD_UGT1A1_48hr, is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.Data from the assay component CLD_UGT1A1_48hr was analyzed at the endpoint, CLD_UGT1A1_48hr, in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase. Is this molecule effective to this assay?",train
788,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5789473684210527,"NVS_ADME_hCYP19A1, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP19A1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP19A1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP19A1, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP19A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""steroidogenesis-related"". Is this molecule effective to this assay?",train
789,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6416666666666667,"NVS_ADME_hCYP1A1, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP1A1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP1A1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP1A1, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP1A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
790,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5499999999999999,"NVS_ADME_hCYP1A2, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP1A2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP1A2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP1A2, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP1A2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
791,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.25,"NVS_ADME_hCYP2A6, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2A6 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2A6 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2A6, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2A6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
792,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4615384615384615,"NVS_ADME_hCYP2B6, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2B6 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2B6 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2B6, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2B6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
793,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5145067698259188,"NVS_ADME_hCYP2C19, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2C19 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2C19 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2C19, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C19. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
794,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3862068965517241,"NVS_ADME_hCYP2C9, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2C9 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2C9 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2C9, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
795,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6181818181818182,"NVS_ADME_hCYP2D6, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP2D6 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP2D6 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP2D6, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2D6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
796,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5066666666666666,"NVS_ADME_hCYP3A4, is one of one assay component(s) measured or calculated from the NVS_ADME_hCYP3A4 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_hCYP3A4 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_hCYP3A4, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP3A4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
797,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8,"NVS_ADME_rCYP2C12, is one of one assay component(s) measured or calculated from the NVS_ADME_rCYP2C12 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ADME_rCYP2C12 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ADME_rCYP2C12, was analyzed in the positive fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2c12. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""cyp"" intended target family, where the subfamily is ""xenobiotic metabolism"". Is this molecule effective to this assay?",train
798,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.787878787878788,"NVS_ENZ_hAChE, is one of one assay component(s) measured or calculated from the NVS_ENZ_hAChE assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_hAChE was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hAChE, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ACHE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""acetylcholinesterase"". Is this molecule effective to this assay?",train
799,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_ENZ_hAMPKa1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hAMPKa1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hAMPKa1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hAMPKa1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PRKAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
800,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3076923076923076,"NVS_ENZ_hAurA, is one of one assay component(s) measured or calculated from the NVS_ENZ_hAurA assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hAurA was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hAurA, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene AURKA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
801,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7603305785123967,"NVS_ENZ_hBACE, is one of one assay component(s) measured or calculated from the NVS_ENZ_hBACE assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hBACE was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hBACE, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene BACE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""aspartate protease"". Is this molecule effective to this assay?",train
802,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_ENZ_hCASP5, is one of one assay component(s) measured or calculated from the NVS_ENZ_hCASP5 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hCASP5 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hCASP5, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""cysteine protease"". Is this molecule effective to this assay?",train
803,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2727272727272727,"NVS_ENZ_hCK1D, is one of one assay component(s) measured or calculated from the NVS_ENZ_hCK1D assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hCK1D was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hCK1D, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CSNK1D. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
804,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8395061728395062,"NVS_ENZ_hDUSP3, is one of one assay component(s) measured or calculated from the NVS_ENZ_hDUSP3 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hDUSP3 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hDUSP3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene DUSP3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""dual-specific phosphatase"". Is this molecule effective to this assay?",train
805,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6000000000000001,"NVS_ENZ_hES, is one of one assay component(s) measured or calculated from the NVS_ENZ_hES assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_hES was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hES, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene BCHE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""pseudocholinesterase"". Is this molecule effective to this assay?",train
806,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6904761904761905,"NVS_ENZ_hElastase, is one of one assay component(s) measured or calculated from the NVS_ENZ_hElastase assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Spectrophotometry technology.Data from the assay component NVS_ENZ_hElastase was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hElastase, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ELANE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""serine protease"". Is this molecule effective to this assay?",train
807,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2380952380952381,"NVS_ENZ_hFGFR1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hFGFR1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hFGFR1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hFGFR1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene FGFR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
808,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4736842105263158,"NVS_ENZ_hGSK3b, is one of one assay component(s) measured or calculated from the NVS_ENZ_hGSK3b assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hGSK3b was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hGSK3b, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene GSK3B. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""serine/threonine kinase"". Is this molecule effective to this assay?",train
809,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2857142857142857,"NVS_ENZ_hMMP1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
810,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4545454545454545,"NVS_ENZ_hMMP13, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP13 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP13 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP13, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP13. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
811,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666666,"NVS_ENZ_hMMP2, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
812,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5324675324675324,"NVS_ENZ_hMMP3, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP3 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP3 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
813,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4444444444444444,"NVS_ENZ_hMMP7, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP7 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP7 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP7, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
814,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8571428571428571,"NVS_ENZ_hMMP9, is one of one assay component(s) measured or calculated from the NVS_ENZ_hMMP9 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence technology.Data from the assay component NVS_ENZ_hMMP9 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hMMP9, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""protease"" intended target family, where the subfamily is ""matrix metalloproteinase"". Is this molecule effective to this assay?",train
815,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.875,"NVS_ENZ_hPDE10, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPDE10 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPDE10 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPDE10, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE10A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""phosphodiesterase"". Is this molecule effective to this assay?",train
816,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3454545454545454,"NVS_ENZ_hPDE4A1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPDE4A1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPDE4A1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPDE4A1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE4A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""phosphodiesterase"". Is this molecule effective to this assay?",train
817,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6358024691358024,"NVS_ENZ_hPDE5, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPDE5 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPDE5 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPDE5, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE5A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""phosphodiesterase"". Is this molecule effective to this assay?",train
818,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6944444444444444,"NVS_ENZ_hPI3Ka, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPI3Ka assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPI3Ka was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPI3Ka, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PIK3CA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""phosphoinositol kinase"". Is this molecule effective to this assay?",train
819,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5777777777777778,"NVS_ENZ_hPTEN, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTEN assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTEN was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTEN, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTEN. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""dual-specific phosphatase"". Is this molecule effective to this assay?",train
820,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2222222222222222,"NVS_ENZ_hPTPN11, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN11 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN11 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN11, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN11. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
821,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1428571428571429,"NVS_ENZ_hPTPN12, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN12 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN12 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN12, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN12. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
822,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7222222222222222,"NVS_ENZ_hPTPN13, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN13 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN13 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN13, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN13. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
823,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5555555555555556,"NVS_ENZ_hPTPN9, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPN9 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hPTPN9 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPN9, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""non-receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
824,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5714285714285714,"NVS_ENZ_hPTPRC, is one of one assay component(s) measured or calculated from the NVS_ENZ_hPTPRC assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_hPTPRC was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hPTPRC, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPRC. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""phosphatase"" intended target family, where the subfamily is ""receptor tyrosine phosphatase"". Is this molecule effective to this assay?",train
825,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5,"NVS_ENZ_hSIRT1, is one of one assay component(s) measured or calculated from the NVS_ENZ_hSIRT1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hSIRT1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hSIRT1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SIRT1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""hydrolase"" intended target family, where the subfamily is ""protein deacetylase"". Is this molecule effective to this assay?",train
826,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3888888888888889,"NVS_ENZ_hSIRT2, is one of one assay component(s) measured or calculated from the NVS_ENZ_hSIRT2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hSIRT2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hSIRT2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SIRT2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""hydrolase"" intended target family, where the subfamily is ""protein deacetylase"". Is this molecule effective to this assay?",train
827,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.75,"NVS_ENZ_hTrkA, is one of one assay component(s) measured or calculated from the NVS_ENZ_hTrkA assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hTrkA was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hTrkA, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene NTRK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
828,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_ENZ_hVEGFR2, is one of one assay component(s) measured or calculated from the NVS_ENZ_hVEGFR2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by Fluorescence and electrophoretic mobility shift technology.Data from the assay component NVS_ENZ_hVEGFR2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_hVEGFR2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""kinase"" intended target family, where the subfamily is ""receptor tyrosine kinase"". Is this molecule effective to this assay?",train
829,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6875,"NVS_ENZ_oCOX1, is one of one assay component(s) measured or calculated from the NVS_ENZ_oCOX1 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_oCOX1 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_oCOX1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTGS1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""cyclooxygenase"". Is this molecule effective to this assay?",train
830,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9545454545454546,"NVS_ENZ_oCOX2, is one of one assay component(s) measured or calculated from the NVS_ENZ_oCOX2 assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_oCOX2 was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_oCOX2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTGS2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""cyclooxygenase"". Is this molecule effective to this assay?",train
831,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.59375,"NVS_ENZ_rAChE, is one of one assay component(s) measured or calculated from the NVS_ENZ_rAChE assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with absorbance signals by Colorimetric technology.Data from the assay component NVS_ENZ_rAChE was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rAChE, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Ache. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""esterase"" intended target family, where the subfamily is ""acetylcholinesterase"". Is this molecule effective to this assay?",train
832,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6,"NVS_ENZ_rCNOS, is one of one assay component(s) measured or calculated from the NVS_ENZ_rCNOS assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_ENZ_rCNOS was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rCNOS, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Nos1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""nitric oxide synthase"". Is this molecule effective to this assay?",train
833,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8055555555555556,"NVS_ENZ_rMAOAC, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOAC assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOAC was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOAC, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maoa. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
834,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5476190476190477,"NVS_ENZ_rMAOAP, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOAP assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOAP was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOAP, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maoa. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
835,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3454545454545454,"NVS_ENZ_rMAOBC, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOBC assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOBC was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOBC, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maob. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
836,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4285714285714286,"NVS_ENZ_rMAOBP, is one of one assay component(s) measured or calculated from the NVS_ENZ_rMAOBP assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_ENZ_rMAOBP was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rMAOBP, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maob. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""monoamine oxidase"". Is this molecule effective to this assay?",train
837,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2727272727272727,"NVS_ENZ_rabI2C, is one of one assay component(s) measured or calculated from the NVS_ENZ_rabI2C assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_ENZ_rabI2C was analyzed into 2 assay endpoints. This assay endpoint, NVS_ENZ_rabI2C, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CKB. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""oxidoreductase"" intended target family, where the subfamily is ""imidazoline receptor"". Is this molecule effective to this assay?",train
838,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3636363636363636,"NVS_GPCR_bAdoR_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_bAdoR_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_bAdoR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bAdoR_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
839,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7142857142857143,"NVS_GPCR_bDR_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_bDR_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_bDR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bDR_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
840,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7912087912087913,"NVS_GPCR_g5HT4, is one of one assay component(s) measured or calculated from the NVS_GPCR_g5HT4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_g5HT4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_g5HT4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
841,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.575,"NVS_GPCR_gH2, is one of one assay component(s) measured or calculated from the NVS_GPCR_gH2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gH2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gH2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Hrh2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
842,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2499999999999999,"NVS_GPCR_gLTB4, is one of one assay component(s) measured or calculated from the NVS_GPCR_gLTB4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gLTB4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gLTB4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Ltb4r. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
843,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5833333333333333,"NVS_GPCR_gLTD4, is one of one assay component(s) measured or calculated from the NVS_GPCR_gLTD4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gLTD4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gLTD4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cysltr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
844,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.763888888888889,"NVS_GPCR_gMPeripheral_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_gMPeripheral_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gMPeripheral_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gMPeripheral_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Chrm3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
845,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6184210526315789,"NVS_GPCR_gOpiateK, is one of one assay component(s) measured or calculated from the NVS_GPCR_gOpiateK assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_gOpiateK was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gOpiateK, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprk1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
846,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6428571428571428,"NVS_GPCR_h5HT2A, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT2A assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT2A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT2A, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
847,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5568181818181819,"NVS_GPCR_h5HT5A, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT5A assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT5A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT5A, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR5A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
848,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4399999999999999,"NVS_GPCR_h5HT6, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT6 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT6, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
849,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4649999999999999,"NVS_GPCR_h5HT7, is one of one assay component(s) measured or calculated from the NVS_GPCR_h5HT7 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_h5HT7 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT7, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
850,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666666,"NVS_GPCR_hAT1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAT1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAT1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AGTR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
851,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7619047619047619,"NVS_GPCR_hAdoRA1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdoRA1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdoRA1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdoRA1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
852,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1666666666666666,"NVS_GPCR_hAdoRA2a, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdoRA2a assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdoRA2a was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdoRA2a, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
853,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4897959183673469,"NVS_GPCR_hAdra2A, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdra2A assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdra2A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdra2A, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRA2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
854,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4358974358974359,"NVS_GPCR_hAdra2C, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdra2C assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdra2C was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdra2C, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRA2C. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
855,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.375,"NVS_GPCR_hAdrb1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdrb1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdrb1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
856,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9393939393939392,"NVS_GPCR_hAdrb2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdrb2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdrb2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
857,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6818181818181819,"NVS_GPCR_hAdrb3, is one of one assay component(s) measured or calculated from the NVS_GPCR_hAdrb3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hAdrb3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
858,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5083333333333333,"NVS_GPCR_hDRD1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hDRD1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hDRD1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
859,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2777777777777777,"NVS_GPCR_hDRD2s, is one of one assay component(s) measured or calculated from the NVS_GPCR_hDRD2s assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hDRD2s was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD2s, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
860,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3703703703703703,"NVS_GPCR_hDRD4.4, is one of one assay component(s) measured or calculated from the NVS_GPCR_hDRD4.4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hDRD4.4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD4.4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
861,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7142857142857143,"NVS_GPCR_hH1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hH1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hH1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hH1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HRH1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
862,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.575,"NVS_GPCR_hLTB4_BLT1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hLTB4_BLT1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hLTB4_BLT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hLTB4_BLT1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene LTB4R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
863,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5111111111111111,"NVS_GPCR_hM1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
864,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4583333333333333,"NVS_GPCR_hM2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
865,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4272727272727272,"NVS_GPCR_hM3, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
866,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6041666666666667,"NVS_GPCR_hM4, is one of one assay component(s) measured or calculated from the NVS_GPCR_hM4 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hM4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM4, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
867,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6761904761904762,"NVS_GPCR_hNK2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hNK2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hNK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hNK2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TACR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
868,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4761904761904761,"NVS_GPCR_hOpiate_D1, is one of one assay component(s) measured or calculated from the NVS_GPCR_hOpiate_D1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hOpiate_D1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hOpiate_D1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene OPRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
869,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5375000000000001,"NVS_GPCR_hOpiate_mu, is one of one assay component(s) measured or calculated from the NVS_GPCR_hOpiate_mu assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hOpiate_mu was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hOpiate_mu, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene OPRM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
870,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.509090909090909,"NVS_GPCR_hTXA2, is one of one assay component(s) measured or calculated from the NVS_GPCR_hTXA2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_hTXA2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hTXA2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TBXA2R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
871,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4,"NVS_GPCR_p5HT2C, is one of one assay component(s) measured or calculated from the NVS_GPCR_p5HT2C assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_p5HT2C was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_p5HT2C, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR2C. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
872,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.44,"NVS_GPCR_r5HT1_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_r5HT1_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_r5HT1_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_r5HT1_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
873,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666666,"NVS_GPCR_r5HT_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_r5HT_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_r5HT_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_r5HT_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
874,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5740740740740741,"NVS_GPCR_rAdra1B, is one of one assay component(s) measured or calculated from the NVS_GPCR_rAdra1B assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rAdra1B was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1B, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1b. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
875,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.72,"NVS_GPCR_rAdra1_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_rAdra1_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rAdra1_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
876,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5961538461538463,"NVS_GPCR_rAdra2_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_rAdra2_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rAdra2_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra2_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra2a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
877,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6333333333333334,"NVS_GPCR_rNK1, is one of one assay component(s) measured or calculated from the NVS_GPCR_rNK1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rNK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rNK1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tacr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
878,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.575,"NVS_GPCR_rNK3, is one of one assay component(s) measured or calculated from the NVS_GPCR_rNK3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rNK3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rNK3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tacr3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
879,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6611111111111112,"NVS_GPCR_rOpiate_NonSelective, is one of one assay component(s) measured or calculated from the NVS_GPCR_rOpiate_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rOpiate_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rOpiate_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprm1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
880,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4818181818181818,"NVS_GPCR_rOpiate_NonSelectiveNa, is one of one assay component(s) measured or calculated from the NVS_GPCR_rOpiate_NonSelectiveNa assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rOpiate_NonSelectiveNa was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rOpiate_NonSelectiveNa, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprm1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
881,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6666666666666667,"NVS_GPCR_rSST, is one of one assay component(s) measured or calculated from the NVS_GPCR_rSST assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rSST was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rSST, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Sstr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
882,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6379310344827587,"NVS_GPCR_rTRH, is one of one assay component(s) measured or calculated from the NVS_GPCR_rTRH assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rTRH was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rTRH, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Trhr. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
883,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.1071428571428571,"NVS_GPCR_rV1, is one of one assay component(s) measured or calculated from the NVS_GPCR_rV1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rV1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rV1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Avpr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
884,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6190476190476192,"NVS_GPCR_rabPAF, is one of one assay component(s) measured or calculated from the NVS_GPCR_rabPAF assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rabPAF was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rabPAF, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PTAFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
885,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.55,"NVS_GPCR_rmAdra2B, is one of one assay component(s) measured or calculated from the NVS_GPCR_rmAdra2B assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_GPCR_rmAdra2B was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rmAdra2B, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra2b. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""gpcr"" intended target family, where the subfamily is ""rhodopsin-like receptor"". Is this molecule effective to this assay?",train
886,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4363636363636363,"NVS_IC_hKhERGCh, is one of one assay component(s) measured or calculated from the NVS_IC_hKhERGCh assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_hKhERGCh was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_hKhERGCh, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene KCNH2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""potassium channel"". Is this molecule effective to this assay?",train
887,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5714285714285714,"NVS_IC_rCaBTZCHL, is one of one assay component(s) measured or calculated from the NVS_IC_rCaBTZCHL assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_rCaBTZCHL was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rCaBTZCHL, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cacna1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""calcium channel"". Is this molecule effective to this assay?",train
888,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8333333333333334,"NVS_IC_rCaDHPRCh_L, is one of one assay component(s) measured or calculated from the NVS_IC_rCaDHPRCh_L assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_rCaDHPRCh_L was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rCaDHPRCh_L, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cacna1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""calcium channel"". Is this molecule effective to this assay?",train
889,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5158730158730158,"NVS_IC_rNaCh_site2, is one of one assay component(s) measured or calculated from the NVS_IC_rNaCh_site2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_IC_rNaCh_site2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rNaCh_site2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Scn1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""sodium channel"". Is this molecule effective to this assay?",train
890,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.525,"NVS_LGIC_bGABARa1, is one of one assay component(s) measured or calculated from the NVS_LGIC_bGABARa1 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_bGABARa1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_bGABARa1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene GABRA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
891,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.875,"NVS_LGIC_h5HT3, is one of one assay component(s) measured or calculated from the NVS_LGIC_h5HT3 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_h5HT3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_h5HT3, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR3A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
892,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5555555555555556,"NVS_LGIC_hNNR_NBungSens, is one of one assay component(s) measured or calculated from the NVS_LGIC_hNNR_NBungSens assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_hNNR_NBungSens was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_hNNR_NBungSens, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRNA2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
893,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5416666666666667,"NVS_LGIC_rGABAR_NonSelective, is one of one assay component(s) measured or calculated from the NVS_LGIC_rGABAR_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_rGABAR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rGABAR_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Gabra1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
894,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4805194805194804,"NVS_LGIC_rNNR_BungSens, is one of one assay component(s) measured or calculated from the NVS_LGIC_rNNR_BungSens assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_LGIC_rNNR_BungSens was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rNNR_BungSens, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Chrna7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""ion channel"" intended target family, where the subfamily is ""ligand-gated ion channel"". Is this molecule effective to this assay?",train
895,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.650390625,"NVS_MP_hPBR, is one of one assay component(s) measured or calculated from the NVS_MP_hPBR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_MP_hPBR was analyzed into 1 assay endpoint. This assay endpoint, NVS_MP_hPBR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TSPO. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""cholesterol transporter"". Is this molecule effective to this assay?",train
896,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7114695340501792,"NVS_MP_rPBR, is one of one assay component(s) measured or calculated from the NVS_MP_rPBR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_MP_rPBR was analyzed into 1 assay endpoint. This assay endpoint, NVS_MP_rPBR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tspo. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""cholesterol transporter"". Is this molecule effective to this assay?",train
897,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5586206896551724,"NVS_NR_bER, is one of one assay component(s) measured or calculated from the NVS_NR_bER assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_bER was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_bER, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
898,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7692307692307692,"NVS_NR_bPR, is one of one assay component(s) measured or calculated from the NVS_NR_bPR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_bPR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_bPR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PGR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
899,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6277777777777778,"NVS_NR_cAR, is one of one assay component(s) measured or calculated from the NVS_NR_cAR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_cAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_cAR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
900,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6583333333333333,"NVS_NR_hAR, is one of one assay component(s) measured or calculated from the NVS_NR_hAR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_hAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hAR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
901,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.53,"NVS_NR_hCAR_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hCAR_Antagonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hCAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hCAR_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1I3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
902,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5257575757575758,"NVS_NR_hER, is one of one assay component(s) measured or calculated from the NVS_NR_hER assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_hER was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hER, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
903,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7857142857142857,"NVS_NR_hFXR_Agonist, is one of one assay component(s) measured or calculated from the NVS_NR_hFXR_Agonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hFXR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hFXR_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
904,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7345679012345679,"NVS_NR_hFXR_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hFXR_Antagonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hFXR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hFXR_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
905,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.517361111111111,"NVS_NR_hGR, is one of one assay component(s) measured or calculated from the NVS_NR_hGR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_NR_hGR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hGR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR3C1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
906,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7050691244239631,"NVS_NR_hPPARa, is one of one assay component(s) measured or calculated from the NVS_NR_hPPARa assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hPPARa was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPPARa, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PPARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
907,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6637931034482757,"NVS_NR_hPPARg, is one of one assay component(s) measured or calculated from the NVS_NR_hPPARg assay. It is designed to make measurements of fluorescent polarization, a form of binding reporter, as detected with fluorescence polarization signals by Fluorescence Polarization technology.Data from the assay component NVS_NR_hPPARg was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPPARg, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PPARG. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
908,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6224489795918366,"NVS_NR_hPR, is one of one assay component(s) measured or calculated from the NVS_NR_hPR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Lysate-based radiodetection technology.Data from the assay component NVS_NR_hPR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PGR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
909,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.715909090909091,"NVS_NR_hPXR, is one of one assay component(s) measured or calculated from the NVS_NR_hPXR assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hPXR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPXR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1I2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
910,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,1.0,"NVS_NR_hRAR_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hRAR_Antagonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hRAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hRAR_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene RARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
911,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8823529411764706,"NVS_NR_hRARa_Agonist, is one of one assay component(s) measured or calculated from the NVS_NR_hRARa_Agonist assay. It is designed to make measurements of fluorescent resonance energy transfer, a form of binding reporter, as detected with fluorescent resonance energy transfer signals by Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology.Data from the assay component NVS_NR_hRARa_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hRARa_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene RARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
912,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7222222222222222,"NVS_NR_hTRa_Antagonist, is one of one assay component(s) measured or calculated from the NVS_NR_hTRa_Antagonist assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with chemiluminescence signals by AlphaLISA immunoassay technology.Data from the assay component NVS_NR_hTRa_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hTRa_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene THRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
913,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5746031746031747,"NVS_NR_mERa, is one of one assay component(s) measured or calculated from the NVS_NR_mERa assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_NR_mERa was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_mERa, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Esr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
914,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7396449704142012,"NVS_NR_rAR, is one of one assay component(s) measured or calculated from the NVS_NR_rAR assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_NR_rAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_rAR, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Ar. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
915,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5466666666666666,"NVS_OR_gSIGMA_NonSelective, is one of one assay component(s) measured or calculated from the NVS_OR_gSIGMA_NonSelective assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_OR_gSIGMA_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_OR_gSIGMA_NonSelective, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Sigmar1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""misc protein"" intended target family, where the subfamily is ""chaperone"". Is this molecule effective to this assay?",train
916,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3625,"NVS_TR_gDAT, is one of one assay component(s) measured or calculated from the NVS_TR_gDAT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_gDAT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_gDAT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
917,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6590909090909091,"NVS_TR_hAdoT, is one of one assay component(s) measured or calculated from the NVS_TR_hAdoT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hAdoT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hAdoT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC29A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""nucleoside transporter"". Is this molecule effective to this assay?",train
918,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5089285714285714,"NVS_TR_hDAT, is one of one assay component(s) measured or calculated from the NVS_TR_hDAT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hDAT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hDAT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
919,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3788819875776397,"NVS_TR_hNET, is one of one assay component(s) measured or calculated from the NVS_TR_hNET assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hNET was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hNET, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
920,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6909090909090909,"NVS_TR_hSERT, is one of one assay component(s) measured or calculated from the NVS_TR_hSERT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_hSERT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hSERT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
921,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5833333333333334,"NVS_TR_rNET, is one of one assay component(s) measured or calculated from the NVS_TR_rNET assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_rNET was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rNET, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
922,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6979166666666667,"NVS_TR_rSERT, is one of one assay component(s) measured or calculated from the NVS_TR_rSERT assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_rSERT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rSERT, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""neurotransmitter transporter"". Is this molecule effective to this assay?",train
923,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6000000000000001,"NVS_TR_rVMAT2, is one of one assay component(s) measured or calculated from the NVS_TR_rVMAT2 assay. It is designed to make measurements of radioligand binding, a form of binding reporter, as detected with scintillation counting signals by Filter-based radiodetection technology.Data from the assay component NVS_TR_rVMAT2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rVMAT2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc18a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""transporter"" intended target family, where the subfamily is ""vesicular transporter"". Is this molecule effective to this assay?",train
924,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5206971677559913,"OT_AR_ARELUC_AG_1440, is one of one assay component(s) measured or calculated from the OT_AR_ARELUC_AG_1440 assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by Luciferase technology.Data from the assay component OT_AR_ARELUC_AG_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARELUC_AG_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
925,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3860544217687075,"OT_AR_ARSRC1_0480, is one of one assay component(s) measured or calculated from the OT_AR_ARSRC1_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_AR_ARSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
926,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4944297082228117,"OT_AR_ARSRC1_0960, is one of one assay component(s) measured or calculated from the OT_AR_ARSRC1_0960 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_AR_ARSRC1_0960 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0960, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
927,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4847926267281106,"OT_ER_ERaERa_0480, is one of one assay component(s) measured or calculated from the OT_ER_ERaERa_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
928,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4645390070921986,"OT_ER_ERaERa_1440, is one of one assay component(s) measured or calculated from the OT_ER_ERaERa_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
929,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5672222222222223,"OT_ER_ERaERb_0480, is one of one assay component(s) measured or calculated from the OT_ER_ERaERb_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
930,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.3432835820895522,"OT_ER_ERaERb_1440, is one of one assay component(s) measured or calculated from the OT_ER_ERaERb_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERaERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
931,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4533390410958904,"OT_ER_ERbERb_0480, is one of one assay component(s) measured or calculated from the OT_ER_ERbERb_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERbERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
932,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2352941176470588,"OT_ER_ERbERb_1440, is one of one assay component(s) measured or calculated from the OT_ER_ERbERb_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_ER_ERbERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
933,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4030501089324619,"OT_ERa_GFPERaERE_0120, is one of one assay component(s) measured or calculated from the OT_ERa_GFPERaERE_0120 assay. It is designed to make measurements of fluorescent protein induction, a form of inducible reporter, as detected with optical microscopy: fluorescence microscopy signals by Microscopy technology.Data from the assay component OT_ERa_GFPERaERE_0120 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0120, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
934,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5165562913907285,"OT_ERa_GFPERaERE_0480, is one of one assay component(s) measured or calculated from the OT_ERa_GFPERaERE_0480 assay. It is designed to make measurements of fluorescent protein induction, a form of inducible reporter, as detected with optical microscopy: fluorescence microscopy signals by Microscopy technology.Data from the assay component OT_ERa_GFPERaERE_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""steroidal"". Is this molecule effective to this assay?",train
935,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4992727272727272,"OT_FXR_FXRSRC1_0480, is one of one assay component(s) measured or calculated from the OT_FXR_FXRSRC1_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_FXR_FXRSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
936,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.33828125,"OT_FXR_FXRSRC1_1440, is one of one assay component(s) measured or calculated from the OT_FXR_FXRSRC1_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_FXR_FXRSRC1_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
937,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.61121534292266,"OT_NURR1_NURR1RXRa_0480, is one of one assay component(s) measured or calculated from the OT_NURR1_NURR1RXRa_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_NURR1_NURR1RXRa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_0480, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
938,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.8006756756756757,"OT_NURR1_NURR1RXRa_1440, is one of one assay component(s) measured or calculated from the OT_NURR1_NURR1RXRa_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.Data from the assay component OT_NURR1_NURR1RXRa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_1440, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ""nuclear receptor"" intended target family, where the subfamily is ""non-steroidal"". Is this molecule effective to this assay?",train
939,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5796941219826792,"TOX21_ARE_BLA_Agonist_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ARE_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ARE_BLA_Agonist_ch1, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
940,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5204968944099378,"TOX21_ARE_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ARE_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ARE_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
941,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.541349338621548,"TOX21_ARE_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_ARE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_ARE_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.   Is this molecule effective to this assay?",train
942,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.0564885496183206,"TOX21_ARE_BLA_Agonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_ARE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
943,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7428874734607218,"TOX21_AR_BLA_Agonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_AR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ch1, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
944,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5725060080789487,"TOX21_AR_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_AR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
945,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6066875653082551,"TOX21_AR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_AR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
946,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5995619798510732,"TOX21_AR_BLA_Antagonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_AR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Antagonist_ch2, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
947,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5592839182632716,"TOX21_AR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_AR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Antagonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
948,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5822862856190636,"TOX21_AR_BLA_Antagonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_AR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
949,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5226020137784844,"TOX21_AR_LUC_MDAKB2_Agonist, is one of one assay component(s) measured or calculated from the TOX21_AR_LUC_MDAkb2_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.Data from the assay component TOX21_AR_LUC_MDAKB2_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
950,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5653927480617119,"TOX21_AhR_LUC_Agonist, is one of one assay component(s) measured or calculated from the TOX21_AhR_LUC_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CALUX luciferase quantitation technology.Data from the assay component TOX21_AhR_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AhR_LUC_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AHR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic helix-loop-helix protein. Is this molecule effective to this assay?",train
951,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5599174934028126,"TOX21_Aromatase_Inhibition, is one of one assay component(s) measured or calculated from the TOX21_Aromatase_Inhibition assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.Data from the assay component TOX21_Aromatase_Inhibition was analyzed into 1 assay endpoint. This assay endpoint, TOX21_Aromatase_Inhibition, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP19A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is steroidogenesis-related. Is this molecule effective to this assay?",train
952,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6574903969270167,"TOX21_AutoFluor_HEK293_Cell_blue, is one of 6 assay component(s) measured or calculated from the TOX21_AutoFluor_HEK293 assay. It is designed to make measurements of artifacts, a form of background reporter, as detected with fluorescence intensity signals by Autofluorescence technology.Data from the assay component TOX21_AutoFluor_HEK293_Cell_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Cell_blue, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence. Is this molecule effective to this assay?",train
953,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6206675224646984,"TOX21_AutoFluor_HEK293_Media_blue, is one of 6 assay component(s) measured or calculated from the TOX21_AutoFluor_HEK293 assay. It is designed to make measurements of artifacts, a form of background reporter, as detected with fluorescence intensity signals by Autofluorescence technology.Data from the assay component TOX21_AutoFluor_HEK293_Media_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Media_blue, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence. Is this molecule effective to this assay?",train
954,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5810499359795134,"TOX21_AutoFluor_HEPG2_Cell_blue, is one of 6 assay component(s) measured or calculated from the TOX21_AutoFluor_HEPG2 assay. It is designed to make measurements of artifacts, a form of background reporter, as detected with fluorescence intensity signals by Autofluorescence technology.Data from the assay component TOX21_AutoFluor_HEPG2_Cell_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Cell_blue, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence. Is this molecule effective to this assay?",train
955,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.934727503168568,"TOX21_AutoFluor_HEPG2_Cell_green, is one of 6 assay component(s) measured or calculated from the TOX21_AutoFluor_HEPG2 assay. It is designed to make measurements of artifacts, a form of background reporter, as detected with fluorescence intensity signals by Autofluorescence technology.Data from the assay component TOX21_AutoFluor_HEPG2_Cell_green was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Cell_green, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence. Is this molecule effective to this assay?",train
956,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5815147625160463,"TOX21_AutoFluor_HEPG2_Media_blue, is one of 6 assay component(s) measured or calculated from the TOX21_AutoFluor_HEPG2 assay. It is designed to make measurements of artifacts, a form of background reporter, as detected with fluorescence intensity signals by Autofluorescence technology.Data from the assay component TOX21_AutoFluor_HEPG2_Media_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Media_blue, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence. Is this molecule effective to this assay?",train
957,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.9366286438529784,"TOX21_AutoFluor_HEPG2_Media_green, is one of 6 assay component(s) measured or calculated from the TOX21_AutoFluor_HEPG2 assay. It is designed to make measurements of artifacts, a form of background reporter, as detected with fluorescence intensity signals by Autofluorescence technology.Data from the assay component TOX21_AutoFluor_HEPG2_Media_green was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Media_green, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence. Is this molecule effective to this assay?",train
958,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4546448087431693,"TOX21_ELG1_LUC_Agonist, is one of one assay component(s) measured or calculated from the TOX21_ELG1_LUC_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.Data from the assay component TOX21_ELG1_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ELG1_LUC_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATAD5.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is atpase. Is this molecule effective to this assay?",train
959,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6294426612197257,"TOX21_ERa_BLA_Agonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ERa_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ch1, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
960,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4509041835357625,"TOX21_ERa_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ERa_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
961,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.547464696718428,"TOX21_ERa_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity.Data from the assay component TOX21_ERa_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
962,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.631393001345895,"TOX21_ERa_BLA_Antagonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ERa_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
963,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6824655095683133,"TOX21_ERa_BLA_Antagonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ERa_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ch2, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
964,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6093308109760758,"TOX21_ERa_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_ERa_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
965,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5671201814058957,"TOX21_ERa_BLA_Antagonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_ERa_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
966,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5871954132823698,"TOX21_ESRE_BLA_ch1 is an assay readout measuring transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity. Data from the assay component TOX21_ESRE_BLA_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ch1, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATF6. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
967,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5534007352941176,"TOX21_ESRE_BLA_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_ESRE_BLA_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATF6. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
968,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5979092492992956,"TOX21_ESRE_BLA_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_ESRE_BLA_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ATF6.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper. Is this molecule effective to this assay?",train
969,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4880858346498157,"TOX21_ESRE_BLA_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_ESRE_BLA_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
970,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5631013369986255,"TOX21_FXR_BLA_Antagonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_FXR_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Antagonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
971,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.604039987632691,"TOX21_FXR_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_FXR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Antagonist_ch2, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
972,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6205761316872428,"TOX21_FXR_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_FXR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
973,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6033386327503975,"TOX21_FXR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_FXR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
974,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.57875150060024,"TOX21_FXR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_FXR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_FXR_BLA_Antagonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
975,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6188350191838158,"TOX21_FXR_BLA_Antagonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_FXR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
976,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6546811397557667,"TOX21_GR_BLA_Agonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_GR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ch1, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
977,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6218630660120021,"TOX21_GR_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_GR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
978,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6136363636363635,"TOX21_GR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity.Data from the assay component TOX21_GR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
979,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6434633259244292,"TOX21_GR_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_GR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Antagonist_ch2, was analyzed in the negative fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
980,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6342085661080072,"TOX21_GR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_GR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Antagonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand gene activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal. Is this molecule effective to this assay?",train
981,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6276698014629049,"TOX21_GR_BLA_Antagonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_GR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
982,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5837925445705026,"TOX21_HSE_BLA_Agonist_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_HSE_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HSE_BLA_Agonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
983,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4562108731466227,"TOX21_HSE_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_HSE_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HSE_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
984,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5573774005486969,"TOX21_HSE_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene  substrate used as the measure of target activityData from the assay component TOX21_HSE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_HSE_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is heat shock protein. Is this molecule effective to this assay?",train
985,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6324175824175824,"TOX21_HSE_BLA_Agonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_HSE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
986,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5972982840452721,"TOX21_MMP_ratio, is one of 2 assay component(s) measured or calculated from the TOX21_MMP assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by homogenous mitochondrial membrane potential assay technology.Data from the assay component TOX21_MMP_ratio was analyzed into 2 assay endpoints. This assay endpoint, TOX21_MMP_ratio_down, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of 6 membrane potential reporter, loss-of-signal activity can be used to understand changes in the signaling. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation. Is this molecule effective to this assay?",train
987,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6024602460246025,"TOX21_MMP_ratio, is one of 2 assay component(s) measured or calculated from the TOX21_MMP assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by homogenous mitochondrial membrane potential assay technology.Data from the assay component TOX21_MMP_ratio was analyzed into 2 assay endpoints. The assay endpoin, TOX21_MMP_ratio_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of membrane potential reporter, gain-of-signal activity can be used to understand changes in the signaling. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation. Is this molecule effective to this assay?",train
988,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5113445378151261,"TOX21_MMP_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_MMP_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
989,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5612812214753963,"TOX21_NFkB_BLA_Agonist_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity. Data from the assay component TOX21_NFkB_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_NFkB_BLA_Agonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
990,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5936708860759494,"TOX21_NFkB_BLA_Agonist_ch2 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_NFkB_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_NFkB_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
991,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5592334494773519,"TOX21_NFkB_BLA_Agonist_ratio is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_NFkB_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_NFkB_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is NF-kappa B. Is this molecule effective to this assay?",train
992,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5486155086062978,"TOX21_NFkB_BLA_Agonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_NFkB_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
993,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6111679018655762,"TOX21_PPARd_BLA_Agonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_PPARd_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
994,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5351815367295244,"TOX21_PPARd_BLA_Antagonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_PPARd_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Antagonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
995,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4732824427480916,"TOX21_PPARd_BLA_Agonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_PPARd_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
996,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6114854746930218,"TOX21_PPARd_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_PPARd_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
997,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5240765573570645,"TOX21_PPARd_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_PPARd_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
998,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5773869346733669,"TOX21_PPARd_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_PPARd_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Antagonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
999,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6309890109890111,"TOX21_PPARd_BLA_Antagonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_PPARd_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1000,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5798479087452472,"TOX21_PPARg_BLA_Agonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_PPARg_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1001,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5964912280701754,"TOX21_PPARg_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_PPARg_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1002,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6390835959919086,"TOX21_PPARg_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity..Data from the assay component TOX21_PPARg_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
1003,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4588414634146341,"TOX21_PPARg_BLA_Antagonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_PPARg_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Antagonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1004,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6109739368998628,"TOX21_PPARg_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_PPARg_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Antagonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
1005,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5456043956043957,"TOX21_PPARg_BLA_Antagonist_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_PPARg_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1006,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6346055979643767,"TOX21_TR_LUC_GH3_Agonist, is one of one assay component(s) measured or calculated from the TOX21_TR_LUC_GH3_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.Data from the assay component TOX21_TR_LUC_GH3_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Agonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
1007,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6045218478940642,"TOX21_TR_LUC_GH3_Antagonist, is one of one assay component(s) measured or calculated from the TOX21_TR_LUC_GH3_Antagonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.Data from the assay component TOX21_TR_LUC_GH3_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Antagonist, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
1008,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5941318814277071,"TOX21_VDR_BLA_Agonist_viability, is one of 2 assay component(s) measured or calculated from the TOX21_VDR_BLA_Agonist assay. It is designed to make measurements of ATP content, a form of viability reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.TOX21_VDR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1009,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.587626582278481,"TOX21_VDR_BLA_Antagonist_ch1 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_VDR_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Antagonist_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1010,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6194457716196847,"TOX21_VDR_BLA_Agonist_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_VDR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Agonist_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1011,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4838748208313426,"TOX21_VDR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_VDR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Agonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
1012,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6587301587301587,"TOX21_VDR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_VDR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Antagonist_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal. Is this molecule effective to this assay?",train
1013,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6411669367909237,"TOX21_VDR_BLA_Antagonist_viability, is one of 2 assay component(s) measured or calculated from the TOX21_VDR_BLA_Antagonist assay. It is designed to make measurements of ATP content, a form of viability reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.TOX21_VDR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1014,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6713248638838476,"TOX21_p53_BLA_p1_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p1_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1015,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5843672456575683,"TOX21_p53_BLA_p1_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p1_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1016,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6098231152326979,"TOX21_p53_BLA_p1_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_p53_BLA_p1_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor. Is this molecule effective to this assay?",train
1017,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5932320441988951,"TOX21_p53_BLA_p1_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_p53_BLA_p1_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1018,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6897012248635861,"TOX21_p53_BLA_p2_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p2_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1019,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.525669859780647,"TOX21_p53_BLA_p2_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p2_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1020,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5858123317297084,"TOX21_p53_BLA_p2_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_p53_BLA_p2_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor. Is this molecule effective to this assay?",train
1021,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5939349391232236,"TOX21_p53_BLA_p2_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_p53_BLA_p2_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1022,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.638158456415948,"TOX21_p53_BLA_p3_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p3_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p3_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1023,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.552051123479695,"TOX21_p53_BLA_p3_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p3_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p3_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1024,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5876212591419084,"TOX21_p53_BLA_p3_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_p53_BLA_p3_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_p53_BLA_p3_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter,  gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor. Is this molecule effective to this assay?",train
1025,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6499999999999999,"TOX21_p53_BLA_p3_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_p53_BLA_p3_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1026,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6303481373027494,"TOX21_p53_BLA_p4_ch1 is an assay readout measuring reporter gene via transcripton factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p4_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1027,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5803642882294567,"TOX21_p53_BLA_p4_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p4_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1028,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5926202069385271,"TOX21_p53_BLA_p4_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1)reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_p53_BLA_p4_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor. Is this molecule effective to this assay?",train
1029,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.626380706921944,"TOX21_p53_BLA_p4_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_p53_BLA_p4_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1030,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.7119801796795406,"TOX21_p53_BLA_p5_ch1 is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the uncleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p5_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ch1, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1031,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5647226596155561,"TOX21_p53_BLA_p5_ch2 is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the cleaved reporter gene substrate and is used to calculate the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. Data from the assay component TOX21_p53_BLA_p5_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ch2, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function. Is this molecule effective to this assay?",train
1032,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6081742374369103,"TOX21_p53_BLA_p5_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.Data from the assay component TOX21_p53_BLA_p5_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ratio, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor. Is this molecule effective to this assay?",train
1033,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.6300889328063242,"TOX21_p53_BLA_p5_viability is an assay readout measuring cellular ATP content and detected with CellTiter-Glo Luciferase-coupled ATP quantitation.TOX21_p53_BLA_p5_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity. Is this molecule effective to this assay?",train
1034,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5174825174825175,"Tanguay_ZF_120hpf_AXIS  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_AXIS assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_AXIS_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_AXIS_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1035,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5225737646640598,"Tanguay_ZF_120hpf_ActivityScore  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_ActivityScore assay. It is designed to make measurements of developmental malformations and mortality as detected with brightfield microscopy and combines scoring from 18 other assay components measuring more specific morphologies.Data from the assay component Tanguay_ZF_120hpf_ActivityScore was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_ActivityScore, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1036,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5997536945812807,"Tanguay_ZF_120hpf_BRAI  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_BRAI assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_BRAI_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_BRAI_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1037,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5559322033898305,"Tanguay_ZF_120hpf_CFIN  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_CFIN assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_CFIN_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_CFIN_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1038,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.2377049180327869,"Tanguay_ZF_120hpf_CIRC  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_CIRC assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_CIRC_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_CIRC_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1039,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4934782608695652,"Tanguay_ZF_120hpf_EYE  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_EYE assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_EYE_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_EYE_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1040,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5321100917431193,"Tanguay_ZF_120hpf_JAW  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_JAW assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_JAW_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_JAW_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1041,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5488683127572016,"Tanguay_ZF_120hpf_Mort  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_Mort assay. It is designed to make measurements of mortality as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_MORT_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_MORT_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1042,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.523109243697479,"Tanguay_ZF_120hpf_OTIC  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_OTIC assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_OTIC_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_OTIC_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1043,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.509829619921363,"Tanguay_ZF_120hpf_PE  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_PE assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_PE_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PE_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1044,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5854700854700854,"Tanguay_ZF_120hpf_PFIN  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_PFIN assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_PFIN_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PFIN_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1045,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.4372881355932203,"Tanguay_ZF_120hpf_PIG  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_PIG assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_PIG_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PIG_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1046,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5524475524475524,"Tanguay_ZF_120hpf_SNOU  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_SNOU assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_SNOU_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SNOU_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1047,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.476890756302521,"Tanguay_ZF_120hpf_SOMI  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_SOMI assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_SOMI_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SOMI_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1048,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5638888888888889,"Tanguay_ZF_120hpf_SWIM  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_SWIM assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_SWIM_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SWIM_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1049,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.47953216374269,"Tanguay_ZF_120hpf_TRUN  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_TRUN assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_TRUN_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_TRUN_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1050,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.5202922077922078,"Tanguay_ZF_120hpf_TR  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_TR assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_TR_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_TR_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
1051,toxcast,ckpts/gimlet_fp3modalnew/checkpoint-10000,0,0,0.45837957824639286,"Tanguay_ZF_120hpf_YSE  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_YSE assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.Data from the assay component Tanguay_ZF_120hpf_YSE_up was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_YSE_up, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL. Is this molecule effective to this assay?",train
